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ABSTRACT 
 
 
 The goals of this dissertation were to explore the role of the Ca2+-sensitive 
transcription factor NFAT in the regulation of smooth muscle contractility. We 
have identified a conserved NFAT binding site that overlaps an intronic SRF-
binding CArG element that has previously been demonstrated to be essential for 
expression of smooth muscle α-actin. Transfection of a reporter construct 
containing the composite CArG/NFAT element, designated SNAP, into SMCs 
resulted in robust basal reporter activity that was sensitive to the 
calcineurin/NFAT pathways inhibitors FK506 and CsA. Mutations to either the 
NFAT or adjacent SRF binding site essentially abolished reporter activity, 
indicating that both were required. Co-immunoprecipitation assays revealed that 
NFATc3 and SRF formed a complex in solution, and that the formation of this 
complex was facilitated by the presence of the SNAP oligonucleotide. Inhibition of 
the calcineurin-NFAT pathway decreased α-actin expression in cultured SMCs, 
suggesting that NFAT plays a role in the expression of smooth muscle contractile 
proteins such as α-actin. To determine if NFAT transcriptional activity is involved 
in modulating urinary bladder smooth muscle contractility, we compared the 
contractile and electrophysiological properties of NFATc3-null mice to wild-type 
mice. UBSM strips taken from NFATc3-null mice displayed an elevated 
contractile response to EFS compared to strips from wild-type mice. This 
increased contractility was due to a decrease in IBTX-sensitive BK current and 
was supported at the molecular level by reduced expression of mRNA for the 
pore-forming α-subunit of the BK channel. Single-channel recordings revealed 
that the β-subunit of the BK channel, which modulates the sensitivity of the BK 
channel to voltage and Ca2+, was not altered. Interestingly, TEA-sensitive KV 
currents, and expression of the pore-forming KV2.1 subunit, were increased in 
the NFATc3-null myocytes. However, the increased contractile response of 
UBSM strips from NFATc3-null mice indicates that, at least in response to 
electrical field stimulation, the downregulation of BK current plays a more 
significant role than does the increase in KV current. Presumably, this is due to 
the prominent role that BK channels play in shaping the UBSM action potential. 
Thus, this dissertation provides evidence that NFAT plays a role in modulating 
smooth muscle contractility via its role in regulating the expression of contractile 
proteins and ion channels and, furthermore, lays the foundation for future 
investigations into the specific role of NFAT in the pathological response of the 
urinary bladder to outlet obstruction.   
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CHAPTER 1: LITERATURE REVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
OVERVIEW OF SMOOTH MUSCLE PHYSIOLOGY 
 
Smooth Muscle Contractility 
 
 The walls of the vasculature and hollow organs of the body, such as the 
urinary bladder, are comprised of smooth muscle. In order to generate force, 
muscle fibers must shorten, or contract. In skeletal muscle, the fundamental 
contractile unit is the sarcomere, which consists of interdigitating arrays of thick 
and thin filaments, comprised of myosin and actin, respectively (Figure 1A). 
Structures known as Z-discs (Figure 1A) serve as attachment points for the thin 
filaments, and the region encompassed by two Z-discs comprises a single 
sarcomere. Sarcomeres stack in series to form myofibrils, and bundles of these 
myofibrils, in turn, form muscle fibers (Meiss, 1995).  
 The contractions of smooth muscle tissues are also mediated by the 
interaction of thick and thin filaments. However, the ultrastructure of the smooth 
muscle contractile machinery is much less clearly defined (Small & North, 1995). 
Smooth muscle lacks sarcomeres and, therefore, does not have the highly 
ordered, striated pattern that accounts for the appearance of skeletal muscle 
(Figure 1B). The thin filaments of the smooth muscle contractile units are 
associated with α-actinin rich structures known as dense bodies that serve as 
attachment points in much the same way as the Z-discs of skeletal muscle 
(Figure 1B; Hathaway et al., 1991; Andersson & Arner, 2004; Meiss, 1995; Small 
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& North, 1995). Intermediate filament proteins, including desmin and vimentin, 
are thought to play a role in maintaining the three-dimensional network of dense 
bodies (Bond & Somlyo, 1982).  
 Smooth muscle myosin is a hexamer consisting of two heavy chains 
(MHC) associated with two pairs of light chains - regulatory light chains of ~20 
kDa each and essential light chains of ~17 kDa (Andersson & Arner, 2004). Two 
myosin heavy chain isoforms, SM1 (~200 kDa) and SM2 (~204 kDa), are formed 
by alternative splicing of a transcript arising from the single MHC gene. The SM1 
isoform contains a 43 amino acid loop in the carboxyl-terminus of the molecule, 
while the same region of the SM2 isoform contains a smaller 9 amino acid 
sequence (Nagai et al., 1989). In addition to the SM1 and SM2 isoforms, 
additional variants can be made via alternative splicing at the amino terminal, 
giving rise to the SM-A and SM-B isoforms. Thus, there are four possible myosin 
heavy chain isoforms expressed in smooth muscle: SM1-A, SM1-B, SM2-A, and 
SM2-B. Although the functional consequences of the splice variants has not been 
fully explored, there have been reports that the SM1/SM2 ratio affects the 
maximal shortening velocities (Hewett et al., 1993), while the SM-A and SM-B 
variants may influence actin-myosin interaction kinetics (Sweeney et al., 1998). 
 According to the sliding filament model of muscle contraction (Huxley & 
Niedergerke, 1954; Huxley & Hanson, 1954), force is generated as the thick and 
thin filaments of each individual contractile unit “slide” past one another, resulting  
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  B 
 
 
 
 
 
 
 
Figure 1. Comparison of skeletal and smooth muscle contractile 
organization. (A) Electron micrograph of a skeletal muscle sarcomere. (Modified 
from Alberts et al., 1989). (B) Schematic illustration of smooth muscle 
cytoskeletal and contractile unit organization (Meiss, 1995). 
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in a shortening of the contractile unit, although the lengths of the individual thick 
and thin filaments themselves do no change. This process is dependent upon  
Ca2+, as will be discussed in the next section. 
 
The Central Role of Calcium in Contractility 
 An elevation of intracellular Ca2+ levels is the trigger that initiates muscle 
contraction (Murphy, 1993). In skeletal muscle tissue, a protein complex 
consisting of tropomyosin and troponin is intimately associated with the actin 
filament. In the resting, non-contractile state, the tropomyosin molecules 
sterically protect myosin binding sites located on the actin filament. Ca2+ can bind 
to troponin, and this binding, in turn, induces an allosteric change in tropomyosin 
that results in the exposure of the myosin binding sites in the actin molecule. The 
globular myosin heads of the thick filament can then interact with these exposed 
actin binding sites. The hydrolysis of ATP provides the energy required for the 
myosin heads to ratchet along the actin filament in a process known as cross-
bridge cycling. This results in a shortening of the individual sarcomeric units and 
the generation of force.  
 Troponin is not found in smooth muscle tissues such as UBSM (Hathaway 
et al., 1991; Small & North, 1995). Thus, the Ca2+-sensitivity of smooth muscle 
contractility is not conferred to it by this thin filament-associated process. Rather, 
the Ca2+-dependent regulation of contractility in smooth muscle depends instead 
upon the phosphorylation state of the regulatory myosin light chain molecules 
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located in the thick filament (Bremel, 1974; Hathaway et al., 1991; Pfitzer, 2001). 
In brief, under low cytosolic Ca2+ conditions, the myosin regulatory light chains 
are not phosphorylated and there is no interaction between the myosin heads 
and actin filaments. When intracellular Ca2+ is elevated, myosin light chain kinase 
(MLCK) can be activated by Ca2+-calmodulin (CaM). MLCK phosphorylates the 
regulatory myosin light chains, shifting the conformation of the myosin molecules 
into one in which cross-bridge formation, and force generation, can occur. A 
second enzyme, myosin phosphatase, dephosphorylates the regulatory light 
chains to reverse this process and return the muscle to the relaxed state (Pfitzer, 
2001) (Figure 2).   
  
Ion Channels in Smooth Muscle Physiology 
 
 The contractions of both skeletal and smooth muscle tissues are 
dependent upon intracellular Ca2+ levels as Ca2+ is required to expose the actin 
binding sites in skeletal muscle and to activate MLCK in smooth muscle tissues. 
Given the dependence of the contractile process on Ca2+, intracellular Ca2+ levels 
must be precisely regulated to meet the contractile needs of the cell. To  
accomplish this regulatory feat, smooth muscle cells rely upon a repertoire of ion 
channels and pumps that serve to modulate, directly or indirectly, intracellular 
Ca2+ levels.  
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Figure 2. Ca2+-dependent regulation of smooth muscle contraction. 
Extracellular Ca2+ influx triggered by receptor activation or membrane 
depolarization initiates the formation of the Ca2+-CaM complex. Ca2+-CaM 
activates the enzyme MLCK, which phosphorylates the regulatory light chains of 
myosin. This shifts the conformation of myosin into one in which interaction 
between the myosin globular heads and actin is favorable. (From Pfitzer, (2001), 
Regulation of myosin phosphorylation in smooth muscle, J. Appl. Physiol. 
91:497-503). 
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Channels mediating extracellular Ca2+ entry 
 In smooth muscle tissues, depolarization of the plasma membrane leads 
to Ca2+ entry through voltage-dependent Ca2+  channels (VDCC) (Thorneloe & 
Nelson, 2005). Under basal conditions, the concentration of cytosolic Ca2+ is low 
(~120 nmol/L; (Williams & Fay, 1986; Knot & Nelson, 1998), while Ca2+ levels in 
the sarcoplasmic reticulum (SR) and extracellular space are in the millimolar 
range. This steep chemical gradient, combined with the negative resting 
membrane potential of SM cells provides a powerful electrochemical driving force 
favoring the flow of Ca2+ into the cytosol from the extracellular space. Stimuli that 
depolarize the cell membrane will open VDCC, trigger a rapid increase in 
intracellular Ca2+ levels, and promote contraction. Conversely, those factors that 
tend to hyperpolarize the membrane, namely outward current through potassium 
(K+) channels, will oppose the influx of extracellular Ca2+ through VDCC and tend 
to relax the cell. The net contractile state of a given cell will be determined, 
therefore, by the balance of forces tending to depolarize or to hyperpolarize the 
cell membrane. 
 The VDCC superfamily of ion channels includes both high voltage- and 
low voltage-sensitive members (Gollasch & Nelson, 1997; Thorneloe & Nelson, 
2005). The high voltage-sensitive members (L-type), consisting of channel 
proteins Cav1.1-1.4 and Cav2.1-2.3, require a larger degree of membrane 
depolarization to be activated than the low voltage-sensitive members (T-type), 
which include Cav3.1-3.3 (Gollasch & Nelson, 1997; Thorneloe & Nelson, 2005). 
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Structurally, VDCCs consist of a single pore-forming subunit (α1) which contains 
four transmembrane-spanning domains (I-IV). Accessory subunits (β, α2/δ, and 
γ) modulate the activity of the α1 subunit. Members of the Cav1 family are 
blocked by dihydropyridines such as nisoldipine and nifedipine, while Cav2 and 
Cav3 are insensitive to these drugs. Although low-voltage sensitive T-type VDCC 
have been identified in urinary bladder preparations from mouse and guinea pig 
(Sui et al., 2001; Wegener et al., 2004) it is currently thought that, at the 
physiologically relevant resting membrane potential of UBSM (-30 to -50 mV), T-
type channels are largely inactivated (half-inactivated at -70 mV) and contribute 
little to the physiology of UBSM tissues (Isenberg et al., 1992). Thus, Ca2+ 
conductance through L-type channels (L-VDCC) is believed to account for the 
bulk of extracellular Ca2+ influx into UBSM. 
 In addition to Ca2+ influx via VDCC, purinergic P2X receptors can also 
serve as a conduit for the influx of extracellular Ca2+. In the urinary bladder, 
parasympathetic stimulation triggers the release of both acetylcholine and ATP 
from nerve varicosities. The released ATP activates P2X1 receptor channels in 
the post-synaptic smooth muscle and leads to spatially restricted Ca2+ and Na+ 
entry which can be detected optically (Heppner et al., 2005; Thorneloe & Nelson, 
2005; Burnstock, 2006). In rodents, P2X receptor signaling plays a significant 
role in the nerve-mediated contractile response (Brading & Williams, 1990), but in 
humans it appears that the cholinergic response dominates (Sibley, 1984), 
although the importance of P2X-mediated signaling may increase during disease 
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states, such as occurs during bladder hypertrophy (Palea et al., 1993; O'Reilly et 
al., 2002).  
 
Intracellular Ca2+channels 
 Ca2+ is released from the SR internal Ca2+ stores by activation of either 
ryanodine receptors (RyR) or IP3 receptors (IP3R). RyR are located on the SR 
membrane. RyR channels can be activated by cytosolic Ca+2, with channel 
opening favored under low cytosolic Ca2+ (1-10 µM) , and inhibition occurring at 
high Ca2+ (1-10 mM) levels (Fill & Copello, 2002). RyRs are also sensitive to 
luminal Ca2+ levels (Ching et al., 2000), an effect that may be mediated by the 
Ca2+-binding proteins, such as calsequestrin, that are located in the SR lumen 
(Beard et al., 2002). Thus, while the activation of RyR in SM is dependent upon 
an elevation in intracellular Ca2+ through VDCC (Collier et al., 2000), the SR Ca2+ 
load also influence Ca2+ release through RyR, and factors that deplete the SR 
(e.g. thapsigargin or cyclopiazonic acid) have been demonstrated to modulate 
RyR Ca2+ release (Nelson et al., 1995; Jaggar et al., 2000; Herrera et al., 2001).  
 Whereas in cardiac and skeletal muscle tissues, activation of RyR 
releases the SR Ca2+ that contributes the bulk of the Ca2+ needed for contraction, 
in smooth muscle tissues such as UBSM, activation of RyR is believed to 
contribute to relaxation rather than contraction (Heppner et al., 1997; Jaggar et 
al., 2000; Herrera et al., 2001; Wellman & Nelson, 2003). This is due to the fact 
that, in SM, Ca2+ release from RyRs can lead to a transient, localized elevation of 
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Ca2+ (10-100 µM) known as a Ca2+  spark (Figure 3) (Nelson et al., 1995; Jaggar 
et al., 1998). These Ca2+ sparks can activate juxtaposed BK (large conductance 
Ca2+ -sensitive K+) channels, leading to a transient outward K+ current known as 
a STOC (spontaneous transient outward current) (Benham & Bolton, 1986). This 
outward current hyperpolarizes the cell membrane and, thus, reduces the open 
probability of VDCC and promotes SM relaxation (Nelson et al., 1995; Jaggar et 
al., 2000).  
 Inositol-1,4,5-triphosphate receptors (IP3R) are also located on the surface 
of the SR and are opened by the binding of IP3 to the cytosolic side of the 
receptor. Intracellular Ca2+ levels can modulate the sensitivity of the IP3R to IP3 in 
a bell-shaped manner, i.e. Ca2+ promotes channel opening at low concentrations 
and inhibits channel opening at higher concentrations (Thrower et al., 2001). The 
constrictive effect of many vasoactive substances such as endothelin-1 (ET-1) or 
angiotensin II (ANG II) is due to the activation of Gq-protein coupled receptors 
and the subsequent generation of IP3 (Andersson & Arner, 2004; Thorneloe & 
Nelson, 2005). Agonist binding to Gq-coupled receptors activates phospholipase 
C (PLC), which hydrolyzes phosphatidylinositol (PI)-4,5-bisphosphate (PIP2) into 
diacylglycerol (DAG) and inositol-1,4,5-triphosphate (IP3). IP3 binds to the IP3 
receptor on the sarcoplasmic reticulum and triggers the release of internal Ca2+. 
In the urinary bladder, one of the most important types of Gq-coupled receptors 
is the M3 muscarinic receptor  
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Figure 3. Ca2+ sparks in smooth muscle tissues. Ca2+release from RyRs in 
smooth muscle can activate juxtaposed BK cahnnels, triggering an outward K+ 
current which tends to hyperpolarize, and therefore relax, the cell. (From 
Wellman and Nelson, (2004), Signaling between SR and plasmalemma in 
smooth muscle: sparks and the activation of Ca2+-sensitive ion channels, Cell 
Calcium, 34:211-229). 
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(Thorneloe & Nelson, 2005). Parasympathetic stimulation of UBSM leads to the 
release of acetylcholine (Ach) from nerve varicosities. This Ach activates post-
synaptic M3 muscarinic receptors and leads to muscle contraction. The 
importance of this signaling pathway in UBSM physiology and function is 
underscored by the fact that blocking muscarinic receptors in UBSM from wild-
type mice using atropine has been reported to reduced the amplitude of 
neuronally-induced contractions by up to 60% (Werner et al., 2007). 
 
Potassium (K+) channels 
 The majority of hyperpolarizing current in SM is carried by potassium (K+) 
channels (Thorneloe & Nelson, 2005). Five classes of K+ channels have been 
identified in various SM preparations: 1) voltage-dependent K+ channels (KV), 2) 
large-conductance Ca2+-sensitive K+ channels (BK), 3) small-conductance Ca2+-
activated K+ channels (SK),  4)ATP-dependent K+ channels (KATP), and 5) 
inward-rectifying K+ channels (Kir). Although both KATP and Kir channels have 
been demonstrated to play significant roles in vascular smooth muscle (Quayle et 
al., 1997), there is no evidence for a role for these ion channels in UBSM and 
neither the KATP blocker glibenclamide nor the Kir blocker Ba2+  has any effect on 
spontaneous contractile activity in UBSM (Imai et al., 2001). The two voltage-
dependent K+ channels, BK and KV channels, as well as SK channels, have been 
shown to play vital roles the physiology of UBSM. 
13
 
 As mentioned previously, in smooth muscle, K+ efflux through BK 
channels serves as a negative feedback mechanism to limit cellular contractility 
by hyperpolarizing the cell membrane (Nelson et al., 1995; Heppner et al., 1997; 
Jaggar et al., 2000; Herrera et al., 2001). These channels are activated by 
membrane depolarization and by local elevation in intracellular Ca2+ levels. BK 
channels are composed of four pore-forming α-subunits (encoded by the Slo1 
gene) that may be associated with modulatory β-subunits.  In smooth muscle, the 
β1-subunit increases the apparent voltage- and Ca2+-sensitivity of the BK 
channel by shifting the current-voltage (I-V) relationship to more negative 
membrane potentials (Brenner et al., 2000; Cox & Aldrich, 2000). BK channels 
are sensitive to block by iberiotoxin (IBTX) and charybdotoxin (CTX), and these 
scorpion venoms have been used extensively to analyze the functional 
significance of BK channels. In isolated myocytes, IBTX treatment increases the 
size and duration of the action potential (Heppner et al., 1997). At the tissue 
level, blocking BK channels increases the duration and peak amplitude of action 
potentials (Kaczorowski et al., 1996; Heppner et al., 1997) and increases the 
force of muscle contraction (Herrera et al., 2000; Imai et al., 2001; Hashitani & 
Brading, 2003). BK block also leads to an increase in the amplitude of 
spontaneous phasic contractions (Herrera et al., 2000; Petkov et al., 2001; 
Hashitani & Brading, 2003).  
 Voltage-gated K+ channels (KV), like BK channels, are composed of 4 
pore-forming α-subunits (Jan & Jan, 1997; Robertson, 1997; Yellen, 2002). The 
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α-subunits from the broad family of KV channel subunits (KV1-11) can form homo- 
or heteromultimeric channel complexes. However, only KV1-4 proteins can form 
functional channels. Proteins from the KV5-11 families do not form functional 
channels alone, but combine KV1-4 subunits to form channels with unique 
conductances (Post et al., 1996; Salinas et al., 1997a; Salinas et al., 1997b; 
Kramer et al., 1998; Thorneloe & Nelson, 2003).  
 In summary, the excitability of smooth muscle is dictated by the level of 
intracellular Ca2+ which, in turn, is dependent primarily upon Ca2+ influx through 
L-VDCC. Outward current through K+ channels will hyperpolarize the cell 
membrane and tend to relax the cells by reducing the open probability of L-
VDCC. Given the importance of this feedback loop in determining the contractile 
state of smooth muscle, the modulation of K+ channel activity is a fundamental 
aspect in the maintenance of contractility, and transcription factors that contribute 
to the regulation of K+ channel expression should figure prominently in dictating 
the overall contractile status of smooth muscle tissues.  
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REGULATION OF GENE EXPRESSION IN UBSM 
  
Phenotypic modulation of vascular SM 
 
 Smooth muscle has evolved a tissue-specific repertoire of contractile 
proteins, ion channel proteins, and signal transducer molecules, that collectively 
defines the mature contractile phenotype (Owens, 1995). Even in the mature, 
fully differentiated state, vascular SMC are typified by a degree of phenotypic 
plasticity and, upon the proper stimulus, can dedifferentiate from a quiescent, 
contractile phenotype to a proliferative, non-contractile phenotype (Owens, 1995; 
Sobue et al., 1999; Kumar & Owens, 2003; Owens et al., 2004). Dedifferentiation 
is typified by a reduction in the expression of classical SM contractile genes such 
as SM α-actin, SM myosin heavy chain, calponin, SM22α, and smoothelin 
(Wamhoff et al., 2006). This phenotypic modulation can be adaptive in nature, 
such as when vascular smooth muscle cells muscle dedifferentiate and 
proliferate to repair damaged vascular tissues. However, paradoxically, this very 
plasticity can also contribute to pathologies associated with neointimal thickening 
and the narrowing of vascular lumens such as occurs during atherosclerosis and 
restostenosis (Owens et al., 2004). 
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Phenotypic modulation of UBSM  
 
  This process of phenotypic modulation of smooth muscle is not limited to 
vascular smooth muscle tissues. In response to a chronic resistance to urinary 
flow as the result of partial blockage of the urethra, i.e. partial bladder outlet 
obstruction (PBOO), the urinary bladder smooth muscle wall undergoes a 
dramatic remodeling process. The most immediate and obvious response to 
PBOO is a significant increase in the mass of the urinary bladder loosely referred 
to as bladder hypertophy, although the increase in bladder mass is due to both 
hypertrophy and hyerplasia of the UBSM cells (Malkowicz et al., 1986; Levin et 
al., 1990; Levin et al., 1994; Andersson & Arner, 2004), as well as an increase in 
the deposition of connective tissue (Uvelius & Mattiasson, 1984; Tekgul et al., 
1996; Kim et al., 2000). In addition to the increase in bladder mass, chronic outlet 
obstruction also leads to changes in the contractile and urodynamic properties of 
the urinary bladder (Ghoniem et al., 1986; Malkowicz et al., 1986; Levin et al., 
1990; Gosling et al., 2000; Andersson & Arner, 2004). 
 Significant alterations in the expression of contractile proteins are 
associated with outlet obstruction. The hypertrophic growth of bladder muscle 
cells is associated with an increase in the synthesis of contractile proteins (Levin 
et al., 1990; Malmqvist et al., 1991a, b; Levin et al., 1994; Andersson & Arner, 
2004). However, it has been reported that the synthesis of myosin does not keep 
up with the overall increase in tissue mass, and the net result is a reduction in the 
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amount of myosin per unit volume, which contributes to the overall changes in 
the contractile properties of the hypertrophied cells (Malmqvist et al., 1991a). 
Hypertrophied bladders also display a decrease in the ratio of the SM2:SM1 
myosin heavy chain isoforms in rat and rabbit models (Malmqvist et al., 1991a; 
Chiavegato et al., 1993; Burkhard et al., 2001; Austin et al., 2004), although the 
physiological implication of this shift is unclear. In addition to changes in the 
relative expression of SM1:SM2 MHC isoforms, Sjuve et al. (1996) found that the 
hypertrophied bladders of rats expressed more of the myosin heavy chain SM-B 
isoform, which should translate into slower contractile phenotype as compared to 
the faster SM-A MHC isoform. In support of this, a reduction in maximal 
shortening velocity has been reported to occur in hypertrophied bladders (Sjuve 
et al., 1996).  
 Actin levels are also reported to vary as a function of outlet obstruction. 
The bladders of hypertrophied rabbits have been reported to contained less 
smooth muscle α-actin and more γ-actin (Kim et al., 1994). In humans, though, 
hypertrophic growth of the bladder secondary to outlet obstruction is typified by 
an increase in α-actin expression and drop in β-actin (Malmqvist et al., 1991a). 
The implications of these changes in myosin and actin expression are unclear, 
although the alterations in myosin isoform expression seem to indicate that the 
hypertrophied bladder is shifting to a slower muscle phenotype. In support of this 
hypothesis, bladder strips taken from obstructed rabbits were slower to reach 
maximal force development in response to KCl (110 mM), but also maintained 
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peak force for a longer period of time and decayed at a much slower rate than 
tissues from control animals (Su et al., 2003).  
 In summary, smooth muscle tissues are characterized by an ability to 
modulate their functional phenotype in response to environmental cues. This 
phenotypic modulation is associated with changes in the expression of the 
repertoire of proteins that are associated with the contractile phenotype, and 
represents a distinct modulation of genetic expression which, at the most 
fundamental level, derives from alterations in the regulation of transcription of 
contractile-associated genes. In the sections to follow, I will discuss two major 
paradigms of smooth muscle transcriptional regulation: (1) transcriptional 
regulation mediated by serum response factor (SRF) and (2) Ca2+-dependent 
regulation of smooth muscle transcription.  
 
SRF-dependent gene regulation in SM  
 
 Sequence analysis of the regulatory regions of many smooth muscle 
specific genes, such as SM α-actin or myosin heavy chain (SM MHC), reveals 
the presence of a conserved, 10bp motif (CC- (A/T)6-GG) known as the CArG 
box (Kim et al., 1997; Mack & Owens, 1999; Manabe & Owens, 2001; Wamhoff 
et al., 2004). The CArG box was first identified in 1985 as the cis-element 
required for activation of the immediate-early gene c-fos (Treisman, 1985). 
Tresiman, in addition to identifying the CArG box, also identified the transcription 
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factor that interacted with it and termed it Serum Response Factor (SRF). As of 
2003, over 60 genes have been identified that contain conserved CArG boxes 
(Miano, 2003), and virtually all of the CArG-containing genes are either growth-
related or expressed specifically in muscle tissues. The puzzling observation that 
a transcriptional cis-element (CArG) and its trans-acting partner (SRF) could be 
involved in seemingly paradoxical regulatory pathways - i.e. that SRF/CArG 
could be involved in both proliferative (growth genes) and quiescent (contractile 
proteins) pathways - can be explained, in part, by the dependence of SRF 
transcriptional activity on multiple levels of regulatory control.  
 Many smooth-muscle specific genes are characterized by the presence of 
multiple CArG elements (Li et al., 1996; Mack & Owens, 1999; Mericskay et al., 
1999; Manabe & Owens, 2001), while the growth-related genes, such as c-fos, 
are typified by having a single CArG element in the promoter (Treisman, 1985). 
For example, transcriptional regulation of SM α-actin is dependent upon the 
integrity of two CArG elements, designated CArG A and B, located in the 
promoter region of the gene (Mack & Owens, 1999). Transcriptional regulation of 
two other smooth muscle-specific contractile-associated proteins, SM myosin 
heavy chain (Manabe & Owens, 2001) and SM22α (Li et al., 1996), is also 
dependent upon two CArG boxes located in their respective promoter regions. It 
has been proposed that the presence of these two CArG elements acts to restrict 
the expression SMC-specific genes to the appropriate tissues, or rather, that the 
presence of multiple CArG boxes insures that these genes will not be expressed 
20
 
in non-SMC tissues. One explanation for this is that the CArG boxes in these 
SMC-related genes tend to be "imperfect" and to have a relatively lower affinity 
for SRF than the CArG elements of growth related genes (Hautmann et al., 1997; 
Mack et al., 2000). Thus, these imperfect CArG elements would require the 
relatively high level of SRF typically found in smooth muscle tissue to be 
activated or, alternatively, may require the presence of other factors, such as the 
homeodomain protein Mhox (Hautmann et al., 1997), to increase the binding 
affinity of SRF to these "imperfect" CArG elements. In non-smooth muscle 
tissues, which tend to express SRF at lower levels (Croissant et al., 1996; 
Belaguli et al., 1997), these SM-specific genes would not be activated while 
CArG-containing growth genes such as c-fos, which express the higher-affinity 
SRF-binding element and require only a single SRF to be bound, could still be 
transcriptionally active. 
 An alternate model of SRF-dependent, SMC-specific gene expression 
involves the transcriptional co-regulator myocardin (Mycd). The specificity of 
gene expression in this model is not determined by SRF itself, which is 
ubiquitously expressed, but rather by the expression patterns of myocardin, 
which is restricted in its expression to smooth muscle and cardiac tissues (Kumar 
& Owens, 2003; Miano, 2003; Yoshida et al., 2003). Myocardin cannot directly 
bind to DNA itself, but instead associates with SRF and greatly enhances its 
transcriptional activity by up to 3 orders of magnitude (Wang et al., 2001). 
Blocking myocardin expression using siRNA results in a downregulation in the 
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expression of several SM marker genes such as MHC, α-actin, and SM22α (Du 
et al., 2003; Yoshida et al., 2003). Conversely, transfecting non-SMC cells with 
myocardin can result in the expression of the same SMC-specific subset of 
genes (Wang et al., 2001; Chen et al., 2002; Du et al., 2003; Yoshida et al., 
2003). Thus, the transcription of CArG-containing SMC genes may be mediated 
by the interaction of SRF with myocardin, resulting in the tissue-specific 
expression of proteins that are regulated by the ubiquitous transcription factor 
SRF.  
 Transcriptional regulation of SM α-actin, MHC, as well as the SMC protein 
calponin, is dependent not only upon the CArG boxes located in the promoter 
region, but also upon a CArG element located in the first intronic region (Mack & 
Owens, 1999; Miano et al., 2000; Manabe & Owens, 2001). Owens and 
colleagues (Mack and Owens, 1999) analyzed the functional significance of the 
three CArG elements (two promoter and one intronic) located in the SM α-actin 
gene using transgenic mice. A 2600bp segment of the α-actin gene 
encompassing the two promoter CArG boxes and the intronic CArG element was 
inserted into a Lac Z reporter construct. Selective mutations to each of the CArG 
elements, and the resultant constructs were used to make a series of transgenic 
mice in which the in vivo expression patterns of the reporter could be monitored 
as a function of the specific CArG mutations. Mutations to the distal promoter 
CArG element (CArG B) abolished expression in all cell types (SM, cardiac, and 
skeletal muscle). However, a mutation to the intronic CArG element specifically 
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blocked expression in SMC tissues, indicating that the intronic CArG played a 
role in dictating the smooth muscle-specific expression patterns of α-actin.  
 Thus, the transcription of many smooth-muscle related genes is 
dependent upon the interaction between SRF and the CArG box(es). SM-specific 
expression patterns can be modified by the relative stringency of SRF binding to 
a given CArG or CArG-like elements, and may also be influenced by the 
dependence of SRF interaction with other transcriptional cofactors such as 
myocardin.  
 
Ca2+-dependent gene regulation in SM 
 
 While it has been established that the contractility of smooth muscle is 
dependent upon an elevation of intracellular Ca2+ levels (excitation-contraction 
coupling; E-C coupling), we have also come to realize that cytosolic Ca2+ levels 
can also affect gene expression patterns (excitation-transcription coupling; E-T 
coupling). Ca2+-dependent transcriptional regulation in SMC in mediated by two 
prominent transcription factors: CREB (Ca2+-cAMP responsive element binding 
protein) and NFAT. In addition, recent data suggests that the RhoA/ROK 
pathway may also play a crucial role in dictating the phenotypic expression 
patterns of SMC. 
 
 
23
 
Ca2+/cAMP-responsive element binding protein (CREB) 
 A rise in cytosolic Ca2+ can trigger the formation of a Ca2+-CaM complex. 
Ca2+-CaM, in turn, modulates the activity of a wide range of target substrates. 
Ca2+-CaM is involved in the activation of myosin light chain kinase (MLCK) and, 
therefore, plays a critical role in directly regulating SM contraction. In addition, 
Ca2+-CaM plays a crucial role in the regulation of transcription in SM by activating 
Ca2+-CaM-dependent protein kinase (CaMK), which is responsible for 
phosphorylating and activating CREB. Activated CREB regulates the 
transcription of target genes by binding to the Ca2+/cAMP responsive element 
(CRE), a process which requires the transcriptional coactivator CREB-binding 
protein (CBP) (Brindle & Montminy, 1992). 
 Although CREB is a Ca2+-dependent transcription factor and may play a 
role in the regulation of SMC phenotype, one of the major targets of CREB 
regulation is c-fos, a protein whose expression is normally associated with 
growth and proliferation. It has been previously demonstrated that, in cerebral 
vascular smooth muscle, phosphorylation and activation of CREB can be 
triggered by membrane depolarization using 60 mM K+, and that this activation is 
mediated by Ca2+ influx through L-VDCC (Cartin et al., 2000; Stevenson et al., 
2001). The activation of CREB correlated with an increase in the transcription of 
the immediate-early gene c-fos (Cartin et al., 2000), a gene which is known to 
contain a single CRE located just downstream from its CArG box. Thus, in the 
context of the phenotypic plasticity exhibited by SMC, the Ca2+ dependent 
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activation of CREB might actually contribute to the loss of the contractile 
phenotype, or rather, the shift from the contractile to the proliferative phenotype. 
 
The RhoA/ROK pathway 
 This simplified view is challenged by the recent observations that 
membrane depolarization and the influx of intracellular Ca2+ via L-VDCC can lead 
to the increased expression of not only c-fos, but also of various SM-specific 
marker genes that are associated with the contractile phenotype (Wamhoff et al., 
2004). How is it possible that two contrasting physiological end-points both share 
a common signaling stimulus - Ca2+ influx via L-VDCC?  
 While the answer to this fundamental question is still not clear, it is 
believed that the RhoA/ROK (Rho Kinase) pathway plays a crucial role in the 
ability of SMC to selectively follow one phenotypic pathway. The RhoA/ROK 
signaling pathway can be activated by Ca2+ influx via either receptor stimulated 
pathways (e.g. G-protein coupled receptors), or via direct membrane 
depolarization (Sakurada et al., 2003). Expression of a constitutively active form 
of RhoA has been shown to trigger increased expression of SM marker genes 
including SM α-actin, SM MHC, and SM22α (Mack et al., 2001). Owens and 
colleagues (Wamhoff et al., 2004) showed that depolarization of rat aortic VSMC 
with 60mM K+ leads to an increase in the transcription of SM α-actin, SM MHC, 
SM22α, myocardin, and c-fos . However, blocking the RhoA/ROK pathway in 
these cells using the drug Y27632 completely abrogates the increased 
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expression of the contractile proteins (SM MHC, SM α-actin, and myocardin), but 
not of the growth-associated gene c-fos. Conversely, treatment of these VSMC 
with KN-93, a selective CaMK inhibitor, blocks the increased expression of c-fos, 
but not of the SM genes. These studies provide compelling evidence that 
activation of the transcription of SMC marker genes (i.e. SM MHC, SM α-actin), 
many of which are CArG-containing, is mediated by the RhoA/ROK pathway in 
accordance with SRF/myocardin, and the CArG-containing growth genes, such 
as c-fos, are regulated via activation of the CaMK/CREB pathway and SRF 
interaction (Figure 4). A question yet to be resolved by this model, however, is 
how the cell commits to either activation of the CaMK or RhoA/ROK pathways 
since, presumably, concomitant activation of both pathways would result in the 
expression of both proliferative and contractile proteins. 
 
NFAT 
 Ca2+-CaM, in addition to activating CaMK, can also activate the protein 
phosphatase, calcineurin (Cn). The phosphatase activity of calcineurin, in turn, 
triggers the translocation of the transcription factor NFAT into the nucleus where 
it can modulate the expression of target genes. NFAT was first identified and 
characterized in T lymphocytes (Shaw et al., 1988), but has since been shown to 
be active in a wide variety of cell types, including smooth muscle, cardiac and 
skeletal muscle tissues (Rao et al., 1997; Im & Rao, 2004). In the sections to 
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Figure 4. Possible pathways of SMC gene expression involve RhoA/ROK 
and CaMK.  Owens and colleagues have proposed that activation of SMC 
differentiation genes such as α-actin or SM MHC may involve the RhoA/ROK 
pathways and SRF/myocardin interaction at the respective CArG elements. 
Growth-responsive genes, however, may require SRF and CREB binding for 
maximal transcriptional activity.  (From Wamhoff et al., (2004), L-type voltage-
gated Ca2+ channels modulate expression of smooth muscle differentiation 
marker genes via a rho kinase/myocardin/SRF-dependent mechanism, Circ. 
Res., 95:406-416). 
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follow, I will discuss the major aspects of NFAT activation and function in smooth 
muscle, with some emphasis on its potential role in UBSM.  
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NFAT (NUCLEAR FACTOR OF ACTIVATED T CELLS) 
 
 The Structure of NFAT Proteins 
 
 The NFAT proteins are related to the Rel/NK-κB family of transcription 
factors. Structurally, the similarity derives from the namesake Rel-homology 
region (RHR) that, in NF-κB proteins, is proposed to make contact with the 
underlying DNA (Ghosh et al., 1995; Jain et al., 1995; Chytil & Verdine, 1996). 
Functionally, both NFAT and NF-κB proteins share the common characteristics 
of being localized to the cytosol under basal conditions and, upon stimulation, 
translocating to the nucleus where they modulate the transcription of target 
genes (Sen & Baltimore, 1986; Baeuerle, 1991).   
 There are currently 5 identified NFAT isoforms, NFATc1-c4, and NFAT5 
(Figure 5). Differential splicing leads to variants of the NFATc1, NFATc2, and 
NFATc3 isoforms. NFAT5 is the primordial NFAT isoform and is identical to the 
tonicity element binding protein (TonEBP), a protein that, as the name implies, 
plays a role in the cellular response to hypertonic stress (Miyakawa et al., 1999). 
This isoform also shows the highest degree of homology to the NF-κB proteins 
(Lopez-Rodriguez et al., 2001; Stroud et al., 2002). However, unlike other 
members of the NFAT family, NFAT5 appears to be constitutively nuclear and is  
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 Figure 5. Schematic diagrams of the NFAT isoforms.  Note that the 
nomenclature for NFAT has changed since this publication. Currently, the 
accepted format is NFAT1 = NFATc2, NFAT2 = NFATc1, NFAT3 = NFATc4, 
NFAT4 = NFATc3.  (From Rao et al., (1997), Transcription factors of the NFAT 
family: regulation and function, Ann. Rev. Immunol., 15:707-747). 
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regulated by pathways not shared with other members of the NFAT (Lopez-
Rodriguez et al., 2001). This review will focus on the Ca2+-sensitive members of 
the NFAT family (NFATc1-c4). 
 Structurally, there are two major conserved regions that characterize the  
NFAT proteins (Hogan et al., 2003)(Figure 6): (1) the NFAT homology region 
(NHR), which is the regulatory domain of NFAT and (2) the DNA binding domain 
(DBD), also known as the Rel-homology region (RHR). The NHR lies between 
amino acids ~100-400 and contains a series of highly conserved sequence 
motifs that are essential for the regulation of NFAT activity. These include a 
series of serine-rich sequences, designated as SP-1, SP-2, SP-3, SRR-1 and 
SRR-2, and KTS. Under non-stimulated conditions, the serine residues located in 
these sequences are maintained in a phosphorylated state by various kinases 
(Beals et al., 1997; Okamura et al., 2000). At the N-terminal portion of the NHR 
lies the docking site for calcineurin, the protein phosphatase that is responsible 
for dephosphorylating the NFAT serine residues, with the consensus sequence 
PxIxIT. Another noteworthy sequence located within the NHR is the nuclear 
localization signal (NLS), which, as the name implies, plays a role in the nuclear 
translocation of NFAT. 
 The DBD of NFAT lies between amino acids ~400-700. It contains a highly 
conserved sequence RAHYETEG, of which the R, Y, T and E residues are 
believed to make contact with the DNA (Jain et al., 1995). While the NFAT 
proteins show a degree of evolutionary similarity to the Rel/NF-κB proteins, one  
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Figure 6. Conserved NFAT domains and sequence motifs.  The regulatory 
domain, also known as the NFAT homology region (NHR) contains the serine-
rich sequences that are essential to the regulation of NFAT activity. The DNA 
binding domain, or Rel homology region (RHR), is structurally similar to the DNA 
binding domain of Rel proteins.  (From Hogan et al., (2003), Transcriptional 
regulation by calcium, calcineurin, and NFAT, Genes Dev, 17:2205-2232). 
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significant difference is that, while NF-κB proteins are bound to DNA as obligate 
dimers, NFAT proteins rarely interact at DNA as dimers, instead interacting with 
a wide range of transcriptional cofactors (to be discussed in sections to follow). 
An exception to this is NFAT5, which typically binds as a dimer at NF-κb-like 
sites (Jin et al., 2003). Interestingly, while residues located in the C-terminal 
portion of the RHR of NF-κB and NFAT5 stabilize the dimer formation, the 
residues that are involved in the stabilizing the interaction of NFAT and AP-1, the 
canonical NFAT cofactor, are located within the N-terminus portion of the RHR, 
the same region responsible for DNA binding (Chen et al., 1998). 
 The transcriptional activation domains (TADs) of NFAT have not been fully 
characterized. However, some preliminary studies have determined that portions 
of both the N- and C-terminal regions of NFAT may possess TADs. A ~100 
residue region located in the N-terminal of NFAT1 (NFATc2) that resembles the 
acidic activation domains that have been implicated in transcriptional activation in 
other transcription factors, including NF-κB (Schmitz et al., 1994), has been 
identified (Luo et al., 1996). Although these residues are not very well conserved 
across the NFAT isoforms, NFATc1b, NFATc1, and NFATc4 all have acidic 
regions located within the N-terminal portions of the molecule (Rooney et al., 
1995; Park et al., 1996). 
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General Features  of NFAT Activation 
 
Overview of the NFAT activation pathway  
 The transcriptional activity of NFAT is dictated by its subcellular 
distribution. In general, in resting or non-stimulated cells, the regulatory serine 
residues located within the NHR are phosphorylated and NFAT remains localized 
to the cytosol. The classical paradigm of NFAT activation and nuclear 
translocation, first elucidated in immune cells, is shown in Figure 7. Antigen 
binding to the TCR results in the activation of phospholipase C (PLC). PLC 
hydrolyzes phosphatidylinositol (PI)-4,5-bisphosphate (PIP2) into diacylglycerol 
(DAG) and inositol-1,4,5-triphosphate (IP3). IP3 binds to the IP3 receptor on the 
endoplasmic reticulum (ER) and triggers the release of internal Ca2+ . The 
elevated intracellular Ca2+ pool caused by the release of store Ca2+, coupled with 
the influx of extracellular Ca2+, can lead to the formation of a Ca2+/CaM 
(calmodulin) complex that subsequently activates the protein phosphatase 
calcineurin (Cn). Calcineurin dephosphorylates the regulatory serine residues in 
the NHR, leading to a conformation shift in NFAT that exposes a nuclear 
localization signal and facilitates nuclear translocation. In most instances, a 
sustained elevation in intracellular Ca2+ is required to maintain NFAT activation 
and nuclear localization. If intracellular Ca2+ levels drop, or calcineurin activity is 
blocked, nuclear kinases rapidly rephosphorylate NFAT and promote its removal 
from the nucleus (Negulescu et al., 1994; Timmerman et al., 1996). 
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Figure 7. NFAT activation pathway in immune cells.  Activation of the cell-
surface T cell receptor, or Gq-coupled receptors, triggers the formation of IP3, 
which subsequently binds to the IP3Rs and releases SR Ca2+ stores. In immune 
cells, NFAT activation is dependent upon Ca2+ influx via CRAC channels. In 
smooth muscle cells, however, the principle source of Ca2+ for NFAT activation is 
through L-VDCC. (From Hogan et al., (2003), Transcriptional regulation by Ca2+, 
calcineurin, and NFAT, Genes Dev, 17:2205-2232). 
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NFAT nuclear import: Dephosphorylation by calcineurin 
 In unstimulated cells, the serine residues located in the NHR of NFAT are 
phosphorylated and the proteins are confined to the cytosol. The first step in the 
activation of NFAT is the dephosphorylation of these regulatory serine residues 
by calcineurin (Cn), also known as protein phosphatase 2B (PP2B), a Ca2+/CaM 
dependent serine/threonine phosphatase (Klee et al., 1998). Structurally, 
calcineurin is a heterodimer consisting of a Ca2+/CaM-binding catalytic subunit 
(CnA) and a Ca2+-binding regulatory subunit (CnB). Under low cytosolic Ca2+ 
conditions (< 10-7 M), Ca2+ can be found bound to the high affinity Ca2+ binding 
site located in the regulatory subunit, but the enzyme remains in an inactive 
state. An elevation in cytosolic Ca2+ levels, triggered by extracellular Ca2+ influx 
and/or the release of SR Ca2+, can lead to the formation of a Ca2+/CaM complex 
which can bind to the catalytic CnA subunit, displacing an autoinhibitory domain 
and exposing the calcineurin active site (Kissinger et al., 1995). This results in a 
significant increase (up to 20-fold) in the phosphatase activity of Cn. The 
cooperative interaction between Ca2+/CaM and free cytosolic Ca2+ allows 
calcineurin to functionally respond to narrow changes in intracellular Ca2+ levels 
(Stemmer & Klee, 1994)   
 Calcineurin is resistant to okadaic acid, the potent inhibitor of protein 
phosphatase 1 and 2A (Cohen et al., 1996), but is specifically inhibited by the 
immunosuppresants FK506 (tacrolimus) and cyclosporine (CsA). Both FK506 
and CsA bind to proteins - FK binding proteins and cyclophilins, respectively - 
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and the resultant drug/protein complexes bind to calcineurin and inhibit its activity 
(Baumann et al., 1992; Sigal & Dumont, 1992; Wiederrecht et al., 1993). CsA has 
been historically used in transplant surgery to reduce the effects of immune 
rejection of transplanted tissues (Sigal & Dumont, 1992). The ability of CsA to 
block the NFAT-dependent activation of T-cells provided a mechanistic rationale 
for this clinically important property. Experimentally, these selective calcineurin 
blockers are invaluable for defining the NFAT dependence of a given 
physiological or biochemical response. 
 In vitro assays have demonstrated that calcineurin is able to 
dephosphorylate NFAT from a variety of sources including purified NFAT 
(Flanagan et al., 1991), recombinantly expressed NFAT (Luo et al., 1996), and 
endogenous NFAT (Park et al., 1996). In addition, substantial evidence indicates 
that exposure of NFAT-expressing cells, such as cultured immune cells, with 
NFAT activating-stimuli results in the rapid dephosphorylation of NFAT proteins 
(Ho et al., 1994; Northrop et al., 1994; Ruff & Leach, 1995). The fact that the 
okadaic acid, at levels sufficient to block the activity of protein phosphatase 1 and 
2A, does not inhibit the dephosphorylation of NFAT in COS cell extracts indicates 
that calcineurin is directly responsible for the phosphatase activity, and the 
dephosphorylation of NFAT is not the result of calcineurin-initiated phosphatase 
cascade (Luo et al., 1996).  
 The docking site for the NFAT/calcineurin interaction is located within the 
N-terminal region of the regulatory domain and bears the sequence PxIxIT. In 
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addition to the PxIxIT site, NFAT/calcineurin interactions for NFATc1 and 
NFATc3 may be mediated by a second calcineurin docking site located on the C-
terminal side of the regulatory domain (Park et al., 2000; Liu et al, 1999). The 
non-covalent interactions between NFAT and Cn are sufficiently strong that, in 
cells transfected with a constitutively active form of calcineurin, Cn is found to be 
localized to the nucleus with NFAT (Shibasaki et al., 1996; Timmerman et al., 
1996). 
 Dephosphorylation of the serine residues located within the NFAT 
regulatory domain induces a conformational change which exposes the nuclear 
localization signal (NLS) and leads to nuclear import (Shaw et al., 1995; Luo et 
al., 1996; Okamura et al., 2000). There is evidence that an intramolecular 
mechanism is involved in the masking of the NFATc3 NLS (Figure 8) (Zhu et al., 
1998; Zhu & McKeon, 2000). The NLS of NFATc3 lacks any residues that might 
be subject to direct phosphorylation. However, there is a domain containing 
several potential phosphorylation sites located upstream from the NLS that was 
proposed to directly interact with the NLS of NFATc3 in non-stimulated cells. In 
this conformation, the NLS is not accessible to the proteins responsible for 
mediating NFAT nuclear shuttling and, hence, the proteins remain in the cytosol. 
Dephosphorylation of these elements by calcineurin disrupts this intramolecular 
masking, resulting in a conformational shift that exposes the NLS. This allows the 
importins responsible for NFAT translocation to recognize the signal and 
translocate NFAT into the nucleus. 
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Figure 8. Intracellular masking of the NFAT nuclear localization signal.  
When NFAT is inactive and phosphorylated, the nuclear localization signal (NLS) 
is masked by interaction with a phosphorylated region located upstream (region 
Z). A rise in cytosolic Ca2+ levels can activate calcineurin which, in turn, 
dephosphorylates the residues located in the Z region and releases the NLS. 
NFAT can then be translocated to the nucleus. The enzyme CK1α catalyzes the 
reverse reaction and acts to maintain NFAT in the cytosol. (From Zhu and 
McKeon., (2000), Nucleocytoplasmic shuttling and the control of NF-AT 
signaling, Cell Mol. Life Sci., 57:411-420). 
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NFAT nuclear export: The role of nuclear and cytosolic kinases  
 Under resting conditions, NFAT proteins are located in the cytosol as 
phosphoproteins. There are several different kinases, both cytosolic and nuclear, 
that phosphorylate the NFAT regulatory serines and promote the cytosolic 
retention, or nuclear export, of NFAT. Among the best characterized are 
glycogen synthase kinase-3β (GSK-3β), members of the Jun N-terminal kinase 
(JNK) family, casein kinase 1α (CK1α), and Crm-1. 
 GSK-3β is a constitutively active nuclear kinase that was found to be 
responsible for catalyzing the nuclear export of NFATc1 (Beals et al., 1997). 
Transfection and overexpression of GSK-3β in COS cells led to the blockade of 
ionomycin-induced NFATc1 translocation. When NFATc1 proteins containing 
Ser→Ala mutations at several critical regulatory serine residues were co-
transfected with GSK-3β, there was no blockade of ionomycin-induced NFATc1 
nuclear accumulation, indicating that the effect was mediated via phosphorylation 
of the regulatory serine residues of NFATc1. Interestingly, GSK-3β could only 
rephosphorylate NFATc1 after it had also been subject to a priming kinase 
reaction by cAMP-dependent protein kinase (PKA), thus indicating that the 
regulation of NFATc1 subcellular distribution was also dependent upon PKA 
activity. 
 In neuronal cells transfected with a constitutively active form of 
calcineurin, it was found that co-transfection and overexpression of GSK-3β led 
to a 3-fold increase in the rate of NFATc4 nuclear export, while co-transfection 
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with other kinases including JNK, MEKK, CK1α did not inhibit the nuclear 
accumulation of NFATc4 (Graef et al., 1999). Given the fact that JNK, MEKK, 
and CK1α have all been reported to oppose NFAT nuclear accumulation in other 
studies, these findings suggests that there may be tissue-specific differences in 
the responsiveness of NFAT to kinase activity and/or that different NFAT 
isoforms may be regulated by different protein kinases. In support of the latter 
explanation, it has been speculated that there exists enough variation amongst 
the regulatory serine-rich motifs located in the NHR of different NFAT isoforms to 
allow for different kinases to recognize and act upon isoform-specific regulatory 
domains (Hogan et al., 2003).  
 In addition to GSK-3β, c-Jun N-terminal kinases (JNK1-3), which are 
downstream effectors of the Ras/MAPK signaling cascade, have also been 
demonstrated to regulate the phosphorylation status, and thus the subcellular 
distribution and activity, of NFAT proteins. Using nuclear extracts derived from 
COS cells co-transfected with JNK, NFATc3, and NFATc4, Chow et al. (2000) 
found that both JNK1 and JNK2 bound to NFATc3 in vitro, but not to NFATc4. 
The NFAT/JNK interaction was dependent upon Ser163 and Ser165, which are 
located in the N-terminal NHR of the human NFATc3 molecule. NFATc3 
molecules with Ser→Ala mutations at the Ser163 and Ser165 sites were not 
phosphorylated in vitro, and cells transfected with these mutant NFATc3 proteins 
displayed a nuclear distribution of the NFATc3 even in the absence of calcineurin 
stimulation. The observation that mutations to these two serines leads to 
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constitutively nuclear NFATc3 localization indicates that their phosphorylation 
state is a key determinant in the subcellular distribution of NFATc3. Another 
interesting observation from these studies was that JNK activity does not affect 
the nuclear accumulation of NFATc1, NFATc2, or NFATc4, indicating that the 
JNK activity is specifically involved in the regulation of NFATc3. This finding 
leads to the possibility that other NFAT isoforms may be regulated by isoform-
specific kinases as well. Thus, the regulatory dependence of NFATc3 on JNK 
activity integrates the signaling pathways and downstream targets of NFATc3 
with the Ras/MAPK pathway that is required for JNK activation. In addition, the 
specificity of JNK regulation of NFATc3 is one of the examples of the functional 
differences among the various NFAT isoforms. 
    McKeon and colleagues (Zhu et al., 1998; Zhu & McKeon, 2000) have 
identified 2 other kinases, MEKK1 (mitogen-activated protein kinase kinase 1) 
and CK1α (casein kinase 1α), that cooperatively regulate NFATc3 nuclear 
accumulation. However, unlike JNK and GSK3β, which exert their effect in the 
nucleus, MEKK1 and CK1α act in the cytosol to promote the cytosolic retention of 
NFATc3. Transfection and overexpression of CK1α in BHK (baby hamster 
kidney) cells led to a significantly reduction in the rate of NFATc3 nuclear 
accumulation in response to ionomycin treatment, while transfection with a 
dominant-negative form of CK1α led to a net increase in NFATc3 nuclear 
accumulation. NFATc3 and CK1α co-immunoprecipitated in vivo, and this 
interaction was dependent upon the A domain (Figure 9). CK1α phosphorylated 
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residues located within the A domain as well as within the neighboring Z domain, 
which is the putative region that interacts with and masks the NLS. Although the 
activation of MEKK1 also suppressed NFATc3 nuclear accumulation, this action 
was dependent upon the presence of CK1α, and MEKK1 was ineffective when 
co-transfected with DN CK1α. It was determined that MEKK1 did not interact 
directly with NFAT, but instead interacted with CK1α by an undefined mechanism 
to increase its binding affinity to NFATc3 nearly 10-fold. Thus, the authors 
provide a model in which CK1α, stabilized by MEKK1, phosphorylates residues 
located within the A and Z domains of NFATc3. This induces a conformational 
shift that promotes an intramolecular interaction of the NLS of NFAT with the Z 
domain, resulting in masking of the NLS.   
 CK1α, JNK, and GSK3β all exert their effects by phosphorylating serine 
residues located in the NHR. Another nuclear kinase, Crm-1, regulates the 
distribution and activity of NFAT by recognizing and binding to a nuclear export 
signal (NES) and, thus, facilitating the export of NFAT from the nucleus. Zhu and 
McKeon (1999) found that overexpression of Crm-1 had no effect on the 
distribution of NFATc3 in non-stimulated cells, but blocked the ionomycin-
stimulated nuclear accumulation of NFATc3. This effect was dependent upon two 
motifs (NES1 and NES2) located within the NHR, upstream of the A domain from 
Figure 9. Significantly, overexpression of Crm-1 was still able to exert its effect 
on mutant NFAT proteins lacking the NLS, indicating the effects of Crm-1 were 
not mediated by interaction with the nuclear localization signal, as is the case 
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with MEKK1/CK1α (Zhu et al., 1998). They also reported that mutations to both 
the NES1 and NES2 sites resulted in an NFAT mutant that did not translocate to 
the nucleus even in response to co-transfection with a constitutively active form 
of Cn, indicating that the NES sites overlaps with the calcineurin-binding domain. 
Co-transfection with constitutively active Cn also abolished NFATc3-Crm-1 
interactions as determined by co-immunoprecipitation, indicating that, not only do 
the NES sites and Cn-binding domains overlap, but that Crm-1 and calcineurin 
actively compete for this composite binding site. The implication of this model is 
that, if Crm-1 activity is not blocked, it can displace Cn from their overlapping 
binding site(s) and prevent a net nuclear accumulation of NFAT, leading to a  
futile cycle of nuclear import and export.  
 Thus, the activity of both nuclear and cytosolic kinases contributes to the 
cytosolic distribution and, hence, activity of NFAT by phosphorylating key 
residues located within the NHR. The activities of GSK3β, JNK, and Crm-1 
promote the nuclear export of NFAT proteins, while the cooperative effects of 
MEKK1 and CK1α contribute to the masking of the NLS and, thus, oppose the 
activity of calcineurin and promote the cytosolic retention of NFAT.  
 
NFAT transcriptional cofactors 
 One of the most striking characteristics of NFAT is its dependence upon a 
wide variety of transcriptional cofactors (Rao et al., 1997; Hill-Eubanks et al., 
2003; Hogan et al., 2003). NFAT proteins have since been found to interact with 
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an enormous range of proteins including, but not limited to, basic leucine-zipper 
(bZIP) transcription factors (AP-1; Ho et al., 1994), the GATA zinc finger proteins 
(Molkentin et al., 1998; Wada et al., 2002), helix-turn-helix proteins such as Oct 
(Bert et al., 2000), IRF-4 (Furstenau et al., 1999; Hu et al., 2002; Rengarajan et 
al., 2002), and HNF3 (Furstenau et al., 1999), and transcription factors from the 
MADS family including MEF2 (Youn et al., 2000; Meissner et al., 2007) and SRF, 
a topic which will be addressed in Chapter 2 of this dissertation.   
 AP-1, a dimer of the proteins Fos and Jun, whose synthesis is stimulated 
by activation of the PKC/MAPK pathway, was the first identified NFAT partner 
(Ho et al., 1994; Macian et al., 2001). NFAT/AP-1 composite binding sites have 
been identified and sequenced from a wide range of immune response genes. 
They consist of a ~15 base pair segment of DNA in which the AP-1 site is 
invariably located downstream of the NFAT binding site. A classic example of this 
is the distal ARRE-2 from the human IL-2 gene, which bears the sequence: 
AGGAAAaacTGttTCA, with the bold letters representing the NFAT recognition 
nucleotides, and the underlined nucleotides representing the consensus AP-1 
binding site (Jain et al., 1993). The NFAT/AP-1 complex is stabilized by amino 
acids located in the N-terminal region of the NFAT RHR, which interact with basic 
amino acids located in the leucine zipper region of AP-1. This complex is not 
stable in solution, however, and the formation of the NFAT/AP-1/DNA complex is 
~20x more stable than the DNA/NFAT complex alone (Chen et al., 1995).  
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 In addition to AP-1, NFAT has also been demonstrated to interact with 
other members of the bZIP family. The proto-oncogene c-Maf has been reported 
to synergistically transactivate expression of IL-4 expression in immune cells with 
NFATc2 (Ho et al., 1996). However, two other bZIP proteins, ICER (inducible 
cAMP early repressor) (Bodor et al., 2000)and p21SNFT (21-kDa small nuclear 
factor isolated from T cells) (Bower et al., 2002) have been reported to negatively 
affect NFAT activity by blocking NFAT-mediated transactivation of cytokine 
expression. Transcription of the CD28 responsive element (CD28RE) gene 
requires a cooperative interaction between CREB and NFAT at a composite 
binding site located in the CD28RE promoter region. ICER blocks transactivation 
of this gene by competing with CREB for binding to its recognition site, and the 
resultant NFAT/ICER complex is not transcriptionally active. p21SNFT also 
inhibits NFAT-mediated transcriptional activation. At NFAT/AP-1 composite 
elements, p21SNFT can replace Fos in the Fos/Jun dimer that comprises AP-1. 
The resultant p21SNFT/Jun/NFAT complex is not transcriptionally active. Thus, 
while effective NFAT transactivation in many cases is based upon a synergistic 
interaction with one bZIP protein (AP-1), two other bZIP proteins, p21SNFT and 
ICER, have inhibitory effects on NFAT activity. 
 Cooperative interactions between NFAT and zinc-finger proteins from the 
GATA family of transcription factors have been reported from skeletal muscle 
(Musaro et al., 1999), cardiomyocytes (Molkentin et al., 1998), as well as in T 
cells (Avni et al., 2002). Musaro et al. (1999) found that cultured skeletal 
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myocytes exposed to insulin-like growth factor (IGF-1) developed a hypertrophic 
phenotype, and that this effect was blocked by co-treatment with CsA or by 
transfection with a dominant-negative form of Cn, indicating that NFAT was 
playing a central role in this response. Immunostaining revealed that the GATA-2 
and NFATc1 were both co-localized to the same subset of nuclei in hypertrophic 
myocytes. However, despite the presence of NFATc1, NFATc2 and NFATc3 in 
these cells, GATA-2 only co-immunoprecipitated with NFATc1, implying that that 
NFAT-mediated regulation of target genes may be modulated by isoform-specific 
interaction with various transcriptional cofactors. Thus, in skeletal muscle, 
NFATc1 and GATA-2 appear to synergistically regulate the expression of the 
genes that may contribute to the hypertrophic phenotype of skeletal muscle, 
although the specific transcriptional targets were not identified in that study.  
 Similarly, Molkentin and colleagues (Molkentin et al., 1998) have 
demonstrated that NFAT and GATA can synergistically drive a reporter probe 
containing the promoter region of BNP (B-type natriuretic peptide), a marker of 
cardiac hypertrophy. Using a yeast two-hybrid screening system as well as co-
immunoprecipitation studies, they found that NFATc4 interacted with GATA-4, 
and that the formation of the NFATc4/GATA-4 complex was dependent upon an 
interaction between the second zinc finger of GATA-4 and the c-terminal portion 
of the NFATc4 RHR, the same portion of the NFAT RHR that mediates the 
NFAT/AP-1 interaction. Co-expression of NFATc4 and GATA-4 synergistically 
activated the BNP reporter probe 100-fold greater than did GATA-4 alone. 
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Although the results of these experiments would seem to suggests that NFATc4 
plays an essential role in the development of pathological cardiac hypertrophy, 
more recent work by this same group (Wilkins et al., 2002) clearly indicate that 
NFATc3, not NFATc4, is mandatory for the development of cardiac hypertrophy. 
Using NFATc3 and NFATc4 knock-out mice, the authors found that the NFATc3-
null mice displayed a significant reduction in calcineurin-induced cardiac 
hypertrophy, while the loss of NFATc4 expression did not attenuate the 
hypertrophic response. Thus, although NFATc4 can interact with GATA to induce 
cardiac hypertrophy, it appears that, in a more physiological context, it is the 
NFATc3 isoform that is actually more critical in the development of this 
pathology. 
 Proteins from the MADS (MCM1 agamous deficies SRF) family of 
transcription factors have also been widely reported to interact with NFAT 
proteins to cooperatively modulate gene transcription. NFATc2 and MEF2 
cooperatively regulate the apoptosis of thymocytes by activating the immediate-
early gene Nur77 (Youn et al., 2000). The transcriptional activity was mediated 
by the recruitment of p300 and did not involve NFAT binding directly to the DNA. 
Immunoprecipitation assays were used to determine that a full length NFATc2 
protein or an NFAT fragment containing only the c-terminal region (residues 680-
927) were able to bind to MEF2 in vivo. However, an NFAT fragment containing 
only the N-terminal region (residues 1-407) or only the RHR of NFATc2 were 
unable to interact with to MEF2 in vivo. Thus, the region of NFATc2 that interacts 
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with MEF2 is located within the C-terminus of the protein, which is distinct from 
the regions of NFAT that interact with both calcineurin and p300. 
 NFAT has also been demonstrated to interact with MEF2 in the 
modulation of skeletal muscle phenotype (Chin et al., 1998). When cultured 
skeletal myocytes were co-transfected with constitutively active calcineurin and 
reporter constructs containing promoters from a variety of marker genes specific 
for fast- or slow-twitch skeletal muscle, calcineurin selectively stimulated the 
activity of myoglobin (Mb) and troponin I slow (TnIs), genes that are associated 
with the slow-twitch phenotype. Maximal transcriptional activation of these slow-
twitch reporters was dependent upon the presence of two NFAT consensus sites 
in the construct. However, in addition to the conserved NFAT elements, maximal 
reporter expression of the Mb gene also required conserved binding sites for the 
factors Sp1 and MEF2, and reporter constructs containing deletions, or 
mutations, to any other these sites display reduced transcriptional activity in 
response to the constitutive calcineurin.  
 Thus, maximal NFAT transactivation of target genes is dependent upon 
interaction with a wide range  of transcriptional cofactors prominently including 
AP-1, GATA, and MEF. The majority of the reported NFAT/cofactor interactions 
results in transcriptional upregulation of gene expression. However, 
downregulation of transcriptional activity is also possible as is evidenced by the 
effects of p21SNFT and ICER on NFAT transcriptional activity. The dependence 
of NFAT, a Ca2+-sensitive transcription factor, on transcriptional cofactors that 
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may be stimulated by alternative pathways (e.g. the MAP kinase pathway for AP-
1) serves to integrate these signaling cascades with the dynamic Ca2+ 
environment of the cell. 
 
SM-specific Features of NFAT activation 
 
NFAT in smooth muscle: The role of extracellular Ca2+ 
 The activity of NFAT is determined by its subcellular distribution which, in 
turn, is dictated by intracellular Ca2+ levels. In smooth muscle, the influx of 
extracellular Ca2+ is conducted primarily L-VDCC (Knot & Nelson, 1998). It has 
been demonstrated that this influx of Ca2+ via L-type VDCCs is indispensable to 
NFAT activation in smooth muscle tissues. Stimulation of ileal smooth muscle 
tissues with PDGF (platelet derived growth factor) leads to a significant increase 
in NFATc3 nuclear accumulation (Stevenson et al., 2001). However, this is 
completely inhibited by nisoldipine, a dihydropyridine that specifically blocks L-
VDCC and, hence, prevents the influx of extracellular Ca2+. Furthermore, co-
treatment with pinacidil, a KATP channel opener that induces membrane 
hyperpolarization, also completely abrogates NFAT activation by PDGF, 
supporting the crucial role of L-VDCC in the activation of NFATc3 in ileal SM. 
Likewise, the stimulation of NFATc3 nuclear translocation in cerebral vascular 
smooth muscle by UTP is also dependent upon Ca2+ influx via L-type VDCC, and 
is blocked by treatment with pinacidil (Gomez et al., 2002). 
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 Although these previous reports have indicated that membrane 
depolarization and activation of L-VDCC is required for NFAT activation in SM, 
membrane depolarization alone may not be a sufficient signal to drive NFAT 
nuclear translocation SM tissues. Nelson and colleagues (Stevenson et al., 2001) 
found that direct membrane depolarization of ileal SM using 60 mM K+ did not 
trigger an increase NFAT nuclear accumulation (a topic which will be more fully 
discussed in sections to follow), and neither did treatment with the Ca2+ 
ionophore ionomycin (Io). This stands in contrast to the responsiveness of 
neurons, where a brief membrane depolarization using high K+ is sufficient to 
trigger sustained NFATc4 nuclear accumulation (Graef et al., 1999). These 
differences may reflect isoform-specific (i.e. NFATc3 vs. NFATc4) and/or tissue-
specific differences (neuronal vs. SM tissue) in NFAT activation patterns.  
 
NFAT in smooth muscle: The role of the SR Ca2+ stores 
 In addition to being dependent upon external Ca2+ influx via L-VDCC, 
NFAT activation has also been shown to be dependent upon the nature of Ca2+ 
release from the SR (sarcoplasmic reticulum) Ca2+ stores. In smooth muscle 
tissues, Ca2+ release from the SR can occur via the activation of IP3 receptors 
(IP3R) or via ryanodine receptor (RyR) activation. Interestingly, however, 
although the activation of either RyR or IP3R leads to the release of internal Ca2+ 
stores, they have been demonstrated to have opposing effects of NFAT 
activation.  
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 As was shown in Figure 7, the activation of IP3R, and the subsequent 
release of SR Ca2+, has been shown to be a fundamental part of the NFAT 
activation pathway in immune cells. In smooth muscle tissues as well, the 
release of SR Ca2+ via activation of IP3R has also been shown to be crucial for 
NFAT activation. Exposure of native cerebral vascular arteries to UTP, a Gq/11-
coupled receptor agonist that activates PLC and leads to the generation of IP3, 
causes a significant increase in NFATc3 nuclear localization (Gomez et al., 
2002). However, this effect is blocked completely by pre-treatment of the arteries 
with the SERCA (smooth endoplasmic reticulum Ca2+ ATPase) inhibitor 
thapsigargin, a drug that prevents the refilling of SR Ca2+ stores. Similarly, co-
treatment of UTP with the IP3R antagonists xestospongin or 2-APB also 
abolishes the effects of UTP on NFATc3 nuclear accumulation, indicating the 
Ca2+ release from the SR via IP3R is indispensable to NFATc3 nuclear 
translocation in cerebral VSM. 
 In contrast to the dependence of NFATc3 nuclear translocation on the 
activation of IP3R, the activation of RyRs was found to have an inhibitory effect 
on the UTP-induced nuclear accumulation of NFATc3 in cerebral arteries 
(Gomez et al., 2002). Likewise, blocking RyRs and, thus, inhibiting the release of 
SR Ca2+ via RyRs, has a potentiating effect on UTP-mediated NFATc3 nuclear 
accumulation. These findings would seem to indicate that Ca2+ release from the 
RyR was activating BK channels, an effect that, in vascular smooth muscle cells, 
has been demonstrated to hyperpolarize the cell membrane and would be 
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expected to reduce the open probability of VDCC and, hence, reduce NFAT 
activation. Thus, blocking Ca2+ spark activity would be predicted to increase Ca2+  
influx via VDCC. However, when the membrane potential was clamped with 60 
mM external K+, conditions in which the outward flux of K+ ions would be 
prohibited, the potentiating effects of RyR were still apparent. Thus, it appears 
that Ca2+ sparks may play some novel role in the regulation of NFAT activation 
that is not directly due to activation of BK channels. 
 Thus, in smooth muscle cells, the activation of NFAT appears to be 
influenced by both extracellular and intracellular Ca2+ pathways. NFAT nuclear 
translocation is dependent upon the influx of extracellular Ca2+ via L-VDCC and 
upon the release of SR Ca2+ through the activation of IP3R. In contrast, the 
release of SR Ca2+ via RyR in the form of Ca2+ sparks has an inhibitory effect of 
NFAT nuclear translocation, although the mechanistic basis of this effect remains 
unclear. 
 
JNK and NFAT nuclear export in SMC 
 Using JNK2-/- mice, Nelson and co-wokers (Gomez et al., 2003) have 
shown that the subcellular distribution of NFATc3 is dependent upon JNK 
activity. As was previously mentioned, HK (60 mM K+) does not induce NFATc3 
nuclear accumulation in the isolated cerebral arteries of wild-type mice 
(Stevenson et al., 2001; Gomez et al., 2002). However, JNK2-/- animals do 
display a significant nuclear accumulation of NFATc3 in response to HK (Gomez 
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et al., 2003). This observation indicates that, in wild-type mice, HK is able to 
stimulate NFATc3 nuclear translocation, but JNK2 activity rapidly removes it from 
the nucleus. Interestingly, while HK fails to induce a net accumulation of NFATc3 
in the wild-type animals, treatment with UTP does lead to a net nuclear 
accumulation of NFATc3 in these same animals. Analyses using antibodies that 
recognizes the active, phosphorylated form of JNK (p-JNK) revealed that 
treatment with UTP, in addition to stimulating NFAT nuclear accumulation via 
elevating intracellular Ca2+ levels, also suppresses the activity of JNK, i.e. there 
was less of the active p-JNK presence after UTP treatment. Thus, these findings 
suggest that certain stimuli, such as UTP, are able to trigger a net increase in 
NFATc3 nuclear accumulation by stimulating the pathways that lead to NFATc3 
nuclear import while simultaneously inhibiting the kinases (e.g. JNK2) that 
contribute to NFAT nuclear export. In addition, it also indicates that the failure of 
certain stimuli to induce NFAT nuclear accumulation (i.e. 60 mM K+) may actually 
reflect an inability of the stimuli to inhibit export mechanisms, rather than a failure 
to stimulate nuclear import mechanisms. This, in turn, contributes to a model of 
NFAT regulation in which episodic stimulatory events are overlaid upon a 
constitutively active nuclear export mechanisms (Zhu & McKeon, 2000; 
Stevenson et al., 2001). 
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NFAT and Pressure 
 One of the more recent physiological factors that has been found to 
contribute to the regulation of NFAT activity is intraluminal pressure. Using 
cannulated cerebral vascular arteries, Gonzalez Bosc et al. (2004) found that, 
under physiologically relevant intraluminal pressures (~100 mm Hg), NFATc3 
displays a prodominantly nuclear distribution. However, the nuclear localization 
of NFAT under these conditions is blocked if the endothelium is denuded, and is 
abrogated by blockade of either nitric-oxide synthase or PKG activity, indicating 
that NO signaling is an essential component of the pressure-induced NFAT 
activation. The fact that treatment with 60mM K+ alone is not a sufficient stimulus 
for NFATc3 nuclear accumulation, but exogenous administration of NO combined 
with 60 mM K+ does result in NFATc3 nuclear localization, lends further support 
for a role for NO signaling in the regulation of NFAT in vascular smooth muscle.  
 These findings suggest that NO signaling is involved in the regulation of 
NFAT nuclear export mechanisms in cerebral vascular arterial smooth muscle. In 
wild-type animals, blockade of PKG leads to a significant decrease in the degree 
of NFATc3 nuclear staining. However, PKG inhibition has no effect on the 
accumulation of nuclear NFATc3 in arteries from JNK2 knock-out mice under the 
same conditions. This indicates that, in vascular smooth muscle, NFATc3 is 
localized to the nucleus under physiological pressure, and that this nuclear 
accumulation is dependent upon the inactivation of JNK2 activity through a 
NO/cGMP/PKG-mediated pathway. 
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The role of NFAT in smooth muscle  
 
 Murphy and colleagues (Boss et al., 1998) were the first to characterize 
NFAT expression and activity in smooth muscle cells. They found that cultured 
VSMC expressed the NFATc1 and NFATc2 isoforms. Under basal conditions, 
NFATc1 was found primarily in the cytosol, while NFATc2 was found to be 
localized to the nuclei of these same cells. Although the SMC-specific targets of 
NFAT activity were not studied, they showed that Io/PMA treatment could drive 
the activity of an NFAT-responsive promoter-reporter construct, as could 
treatment with the smooth muscle mitogen PDGF. 
 Much of the early research on NFAT in smooth muscle focused on the 
Ca2+ requirements for activation (Stevenson et al., 2001; Gomez et al., 2002; 
Gomez et al., 2003). These studies laid the groundwork for an understanding of 
the activation requirements of NFAT in smooth muscle tissues. More recent work 
has focused on exploring the functional role of NFAT in smooth muscle tissues 
and can be broken up into two broad (and somewhat overlapping) categories: (1) 
NFAT and the modulation of smooth muscle phenotype and (2) NFAT and SMC 
contractility.  
 
NFAT and SMC phenotypic modulation 
 Smooth muscle cells, even in the mature, fully differentiated state, are 
typified by a degree of phenotypic plasticity and, upon the proper stimulus, can 
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modulate from a quiescent, contractile phenotype to a proliferative, non-
contractile phenotype (Owens, 1995; Sobue et al., 1999; Kumar & Owens, 2003). 
In culture, SMCs can be "forced" to express either a differentiated or 
dedifferentiated phenotype, most often by modulating the amount of serum in the 
media. Cells maintained in media containing low (1%) levels of serum media 
maintain a differentiated phenotype, characterized by the expression of various 
SMC-associated proteins such as SM MHC or SM α-actin, while higher levels of 
serum (10%) induce a dedifferentiated, proliferative phenotype in which the 
expression of these contractile proteins is typical lost or reduced. This property 
has been used extensively by many researchers to explore the potential role of 
NFAT in the phenotype expression patterns of various SMC tissues. 
 In smooth muscle tissue, GATA-6 and NFATc1 cooperatively regulate the 
expression of SM myosin heavy chain (Wada et al., 2002). The interaction 
between NFATc1 and GATA-6, as determined by co-immunoprecipitation 
experiments, was dependent upon the zinc-finger domain on GATA, as was 
previously reported for the interaction of GATA-4 and NFATc4 in cardiac tissues 
(Molkentin et al., 1998). GATA-6 and NFATc1 were able to synergistically 
transactivate a reporter plasmid containing a 1346bp segment of the SM-MHC 
promoter region. Exposure of the cultured VSMC to 1% serum induced a 
differentiated phenotype and resulted in the translocation of NFATc1 to the nuclei 
of the differentiated VSMCs. In addition, this differentiation also led to the 
transactivation of the SM-MHC reporter, which was blocked by the presence of 
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CsA and FK506. These observations indicate that NFAT is essential to the 
transcriptional upregulation of SM-MHC in response to stimuli that trigger 
expression of the contractile phenotype.  
 Similarly, it has been reported that NFAT activity is an integral part of the 
gene expression patterns associated with the differentiated phenotype of cultured 
visceral smooth muscle cells. Ohkawa et al. (2003) found that dedifferentiated, 
cultured SMC could be induced to develop a differentiated phenotype by 
culturing in media containing IGF-1 (insulin-like growth factor-1). Adding CsA or 
FK506 reversed the modulation, converting the spindle-shaped, differentiated 
cells into cells that exhibited fibroblastic or dedifferentiated morphology. The 
differentiated SMC exhibited nuclear localization of calcineurin, while in 
dedifferentiated cells, CN was found localized to the cytosol. CsA and FK506 
treatment also led to a downregulation of the SMC markers caldesmon (CaD) 
and α1- integrin in dose- and time-dependent fashion. Likewise, blocking CN 
activation with CAIN (a natural CN inhibitor) reduced the activity of a CaD and 
α1- integrin reporter. Thus, these observations also support a role for NFAT in 
the maintenance of the differentiated, contractile phenotype. 
 Lamaziere and coworkers (Larrieu et al., 2005)  also found that NFAT 
activation was essential to the expression of the differentiated SMC phenotype. 
Culturing SMC in serum-free media for up to 21 days led to the shift from a 
fibroblastic morphology to a more classical, spindle-shaped SMC morphology. In 
addition, the levels of SM MHC increased over this same time frame. However, 
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culturing these cells in the presence of CsA blocked the increase in SM MHC 
expression. In the dedifferentiated, proliferative state, NFATc1 was localized to 
the cytosol. However, induction of the differentiated phenotype led to a significant 
increase in the levels of NFATc1 nuclear accumulation. These finding suggest 
that the development of the differentiated phenotype is accompanied by the 
increase in the expression of SM MCH concomitant with an increase in NFATc1 
nuclear accumulation, and that blockade of NFAT activation with CsA is sufficient 
to prevent differentiation.  
 However, there have also been reports that NFAT activation is associated 
with the expression of the proliferative, rather than differentiated, phenotype.   
Rao and colleagues (Yellaturu et al., 2002) report that, in cultured rat thoracic 
arterial SMC, stimulation with the smooth muscle mitogen PDGF led to NFATc1 
translocation to nucleus. PDGF treatment also stimulated cellular proliferation as 
measured by H3-thymidine uptake, and this proliferation was blocked by co-
incubation with CsA.  VIVIT, an NFAT competitor peptide, also inhibited DNA 
synthesis and proliferation, indicating the NFAT activation was essential to the 
proliferative growth of these cells. Although NFAc1, NFATc2 and NFATc3 were 
found to be expressed in these cells, only NFATc1 was found in the nucleus.  
 Thus, although there is lack of uniformity as to whether NFAT activation is 
associated with the proliferative or differentiated phenotype, it does seem likely 
that NFAT does, indeed, play a role in the phenotypic modulation. It is possible 
that the contrasting results (i.e. NFAT supporting the proliferative vs. 
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differentiated phenotypes) may be isoform-specific in nature. However, given that 
the NFATc1 isoform was implicated in both the proliferative (Yellaturu et al., 
2002) and differentiated (Wada et al., 2002; Larrieu et al., 2005) phenotypes, this 
explanation seems unlikely. It is possible that the nature of the stimulus used to 
induce the differentiated or proliferative phenotype may affect the outcome. For 
instance, when phenotype is manipulated by changes in serum levels (Wada et 
al., 2002; Larrieu et al., 2005), NFAT activation is associated with the 
differentiated phenotype. However, when mitogens such as PDGF are used, 
NFAT activation is associated with the proliferative phenotype (Yellaturu et al., 
2002). One possible explanation is that differential stimulus paradigm activate 
different signaling cascade and, ultimately lead to the activation of different sets 
of potential NFAT transcriptional cofactors. In this paradigm, it is the presence of 
specific NFAT cofactors that would dictate the phenotypic outcome, rather than 
the outcome being influenced by NFAT activity alone.  
  
NFAT and SMC contractility 
 Recent works indicate that NFAT plays a central role in the maintenance 
of smooth muscle contractility. NFAT activity, as mentioned previously, has been 
associated with maintenance of the differentiated, contractile phenotype in 
several studies (Wada et al., 2002; Gonzalez Bosc et al., 2004; Larrieu et al., 
2005). NFAT has been implicated in the regulation of contractile proteins such as  
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SM MHC (Wada et al., 2002; Gonzalez Bosc et al., 2004; Larrieu et al., 2005) 
and caldesmon and α-1 integrin (Ohkawa et al., 2003).  
 Recently, Santana and colleagues (Amberg et al., 2004) have 
demonstrated that NFATc3 can also regulate the expression of ion channels that 
contribute to the membrane potential, and therefore contractile status, of smooth 
muscle tissues. Administration of ANGII led to reduction in KV currents in mice, 
and in mRNA for KV2.1. Co-administration of CsA reduced the downregulation of 
KV2.1, and mice expressing a constitutively active form of NFATc3 recapitulated 
these effects in the absence of ANGII. In addition, when NFATc3-/- mice were 
subject to ANGII treatment, they did NOT show any changes in KV current or 
KV2.1 channel expression. These data indicate that NFATc3 is responsible for 
downregulating the expression of KV2.1 in cerebral vascular SMC. Given that KV 
channels play a central role in the maintenance of the resting membrane 
potential and afterhyperpolarization of SMC, these findings also indicate that 
NFAT must also be central to smooth muscle contractility and function. 
 In the Chapters to follow, I will present data that lend further support for a 
role for NFAT in the regulation of SM contractility through its role in regulating the 
expression of both ion channel and contractile proteins. 
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HYPOTHESES 
 
 The central role of Ca2+ in dictating the contractile state of smooth muscle, 
as has been discussed in this literature review, is well-established. According to 
this classic excitation-contraction coupling (E-C) model (Wray et al., 2005), 
excitation of the muscle cell leads to depolarization and Ca2+ entry through 
VDCC. This elevates the intracellular Ca2+ pool and, ultimately, leads to muscle 
contraction (Figure 9). However, it is also widely recognized  that this elevation in 
intracellular Ca2+ can, in addition to activating contraction (E-C coupling), also 
modulate the transcriptional environment of the cell through the activation of 
Ca2+-sensitive transcription factors (E-T coupling) (Hill-Eubanks et al., 2003; 
Barlow et al., 2006; Wamhoff et al., 2006). Thus, the dynamic Ca2+ environment 
of the cell dictates not only its instantaneous contractile status by engaging the 
contractile apparatus (contraction) or opening BK channels (relaxation), but can 
also modulate the long-term transcriptional changes in the expression of 
contractile proteins and ion channels that, in turn, modulate contractility.   
 This thesis examines the role of the Ca2+-sensitive transcription factor 
NFAT in the regulation of smooth muscle contractility. Using a wide range of 
tools, from physiological examinations of UBSM contractility to molecular 
analysis of the expression of ion channels, we have sought to investigate two 
primary hypotheses are investigated. 
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Figure 9. Integration of E-C and E-T coupling pathways. Extracellular Ca2+ 
entering the cell through L-VDCC can stimulate both contraction (E-C coupling) 
and transcriptional pathways (E-T coupling). Data presented in this thesis 
indicates that activation of the NFAT pathway can lead to changes in the 
expression of α-actin (Chapter 2), as well as BK and KV channels (Chapter 3). 
 
 
 
 
 
Hypothesis 1: NFAT contributes to the contractile state of smooth muscle 
via its role in regulating the expression of α-actin. 
 The smooth muscle contractile phenotype is characterized by the 
expression of a subset of proteins that are associated with the contractile 
process. Several of these proteins, including myosin heavy chain, caldesmon,  
and α-integrin, have been reported to be targets of NFAT transcriptional activity, 
which strongly suggests that NFAT is a crucial regulator of smooth muscle 
phenotypic expression. 
  We have identified a conserved NFAT binding site located within the first 
intronic region of the SM α-actin gene that overlaps with a CArG box that has 
previously been demonstrated to be essential to SM α-actin expression.  Here we 
provide evidence that NFAT and SRF cooperatively regulate the expression of α-
actin at this composite binding site. Mutations to either the SRF- or NFAT-
conserved sequences abolished reporter activity, indicating that the activity of 
both transcription factors was required to drive expression. In cells transfected 
with a luciferase reporter containing these conserved elements, stimulation of the 
NFAT pathway with Io/PMA lead to a ~4 fold increase in reporter activity. Using 
co-immunoprecipitation assays, we found that NFATc3 and SRF formed a 
complex in solution via co-immunoprecipitation, and this interaction was 
facilitated by the presence of an oligonucleotide contained the conserved 
NFAT/SRF site. Finally, inhibition of the NFAT pathway using FK506 and CsA 
resulted in a reduction in the expression of SM α-actin in cultured smooth muscle 
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cells. These findings represent the first reports directly linking NFAT activity to 
the expression of SM α-actin and provide further evidence supporting a role for 
NFAT activity in the maintenance of the smooth muscle contractile phenotype. 
 
Hypothesis 2: NFAT activity contributes to the regulation of UBSM 
contractility via modulation of the expression of ion channels. 
 Ca2+ is central to the contractile machinery of smooth muscle myocytes as 
it is required to activate the contractile machinery. Given that the primary source 
of contractile Ca2+in smooth muscle tissues is supplied via L-VDCC, the overall 
contractile state of a smooth muscle myocyte will be dictated by the effect of 
factors that tend to hyperpolarize or to depolarize the cell as their sum effect will 
determine the membrane potential of the cell and, therefore, the open probability 
of L-VDCC . 
  In UBSM cells, current through K+ channels provides the bulk of 
hyperpolarizing current and the activity of these channels is crucial to regulating 
the contractile properties of these cells. Recently, it has been reported that 
NFATc3 may regulate the expression of KV2.1 channels in both vascular smooth 
muscle and in cardiac myocytes. In addition, NFATc3 has also been implicated in 
the regulation of the β1-subunit of the BK channel. Given the prominent roles of 
these ion channels in shaping the UBSM action potential, and in the regulation of 
UBSM membrane potential, these findings suggest that NFATc3 may further 
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contribute to the regulation of smooth muscle contractility via the modulation of 
KV and BK channel expression. 
 In the data presented in Chapter 3, we show that, in murine UBSM tissue, 
NFATc3 regulates the expression of both KV2.1 and of the pore-forming α-
subunit of the BK channel. UBSM from NFATc3-null mice display elevated TEA-
sensitive KV currents, and this is supported at the molecular level by an 
upregulation in the expression of mRNA for KV2.1. These mice simultaneously 
display a decrease in IBTX-sensitive BK current and decreased BK channel 
density, and decreased expression for the BK α-subunit. Despite the elevated KV 
currrent, UBSM strips from NFATc3-null mice display enhanced contractility in 
response to EFS than do UBSM strips from wild-type mice, which suggests that, 
at least in response to EFS, the downregulation of BK current plays a more 
significant role than does the elevated KV current. These findings lend further 
support for a role for NFAT in the maintenance of smooth muscle contractility 
through the regulation of BK and KV channels. 
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ABSTRACT 
 
 Expression of α-actin in smooth muscle cells (SMCs) is regulated, in part, 
by an intronic serum response factor (SRF)-binding CArG element. We have 
identified a conserved nuclear factor of activated T cells (NFAT) binding site that 
overlaps this CArG box and tested the hypothesis that this site plays a previously 
unrecognized role in regulating α-actin expression. A reporter construct prepared 
using a 56-bp region of the mouse α-actin first intron containing SRF, NFAT, and 
AP-1 sites (SNAP) acted as an enhancer element in the context of a minimal 
thymidine kinase promoter. Basal reporter activity following expression in SMCs 
was robust and sensitive to the calcineurin-NFAT pathway inhibitors cyclosporin 
A and FK506. Mutating either the NFAT or SRF binding site essentially abolished 
reporter activity, suggesting that both NFAT and SRF binding are required. Basal 
activity in non-smooth muscle HEK293 cells was SRF-dependent but NFAT-
independent and ~8-fold lower than that in SMCs. Activation of NFAT in HEK293 
cells induced an ~4-fold increase in activity that was dependent on the integrity of 
both NFAT and SRF binding sites. NFATc3·SRF complex formation, 
demonstrated by co-immunoprecipitation, was facilitated by the presence of 
SNAP oligonucleotide. Inhibition of the calcineurin-NFAT pathway decreased -
actin expression in cultured SMCs, suggesting that the molecular interaction of 
NFAT and SRF at SNAP may be physiologically relevant. These data provide the 
first evidence that NFAT and SRF may interact to cooperatively regulate SMC-
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specific gene expression and support a role for NFAT in the phenotypic 
maintenance of smooth muscle. 
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INTRODUCTION 
 
 Smooth muscles cells (SMCs), unlike terminally differentiated cardiac and 
skeletal myocytes, are phenotypically dynamic and maintain their differentiated 
phenotype through the regulated expression of a repertoire of smooth muscle-
specific genes (Owens, 1995). This phenotypic flexibility is consistent with the 
physiological demands placed on vascular tissue and may underlie changes in 
smooth muscle structure and function that accompany pathological processes, 
such as those that occur in hypertension and atherosclerosis (Pauletto et al., 
1994; Gorski & Walsh, 2003; Owens et al., 2004).  
 Serum response factor (SRF), a member of the MADS (MCM1, Agamous, 
Deficiens, SRF) family of transcription factors (Shore & Sharrocks, 1995) is 
central to the regulation of a large subset of SMC-specific genes (Owens, 1995, 
1998; Kumar & Owens, 2003). Almost without exception, important regulatory 
regions of these SMC-specific genes contain CArG boxes (CC[A/T]6GG) that are 
indispensable for expression in smooth muscle (Kumar & Owens, 2003). One 
motif that is common to many of these genes is a pair of CArG boxes, designated 
A and B, in the proximal upstream promoter region of the gene. The integrity of 
each of these elements, as well as conservation of their spacing and orientation, 
is required for efficient SMC expression (Kumar & Owens, 2003). In addition to 
proximal CArG boxes, important CArG box-containing regulatory elements have 
been identified in intronic regions of SMC-specific genes, most notably within the 
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first intron of genes for smooth muscle (SM) myosin heavy chain (MHC) and SM 
α-actin (Nakano et al., 1991; Shimizu et al., 1995; Madsen et al., 1998; Mack & 
Owens, 1999; Manabe & Owens, 2001b, a; Kumar & Owens, 2003).   
 SRF transcriptional activity may be modulated by additional cofactors, 
some of which form complexes with SRF-CArG DNA, whereas others act to 
enhance SRF binding to CArG boxes without forming a detectable ternary 
complex (Treisman, 1995; Cahill et al., 1996; Kumar & Owens, 2003). Although 
SRF activity is critically important in the regulation of SMC differentiation and 
SMC marker gene expression, CArG boxes alone are not sufficient to direct 
SMC-specific gene expression; additional cis-elements and trans-acting factors 
are required (reviewed in (Kumar & Owens, 2003). Mechanisms that exist in 
parallel with the SRF-CArG pathway, as well as SRF-intersecting mechanisms, 
contribute to SMC phenotypic modulation and maintenance.  
 One of the more recent entries in the smooth muscle phenotypic 
maintenance derby is the calcium (Ca2+)-dependent transcription factor nuclear 
factor of activated T cells (NFAT), which regulates the expression of genes in a 
diverse array of immune and non-immune cells and is closely linked to 
developmental processes that involve modulation of cellular phenotypes (Rao et 
al., 1997; Chin et al., 1998; Ho et al., 1998; Ranger et al., 1998; Delling et al., 
2000; Graef et al., 2001a; Graef et al., 2001b; Horsley & Pavlath, 2002; Schulz & 
Yutzey, 2004). NFAT also contributes to pathological processes, as exemplified 
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by its role in the etiology of pathological, but not exercise-induced, cardiac 
hypertrophy (Molkentin et al., 1998; Wilkins et al., 2002; Wilkins et al., 2004).  
NFAT activation is regulated primarily through control of its subcellular 
localization (Flanagan et al., 1991; Crabtree & Clipstone, 1994; Rao et al., 1997). 
In response to Ca2+-elevating stimuli, NFAT is dephosphorylated at multiple N-
terminal phosphoserines by the Ca2+-dependent phosphatase, calcineurin, which 
promotes NFAT nuclear translocation and DNA binding competence (Okamura et 
al., 2000; Neal & Clipstone, 2001). NFAT binds DNA with very low affinity in the 
absence of a cofactor, and in general, formation of an NFAT·cofactor complex is 
required for significant NFAT-mediated transcriptional activity. The NFAT family 
consists of four members (NFAT1/c2, NFAT2/c1, NFAT3/c4, and NFAT4/c3) that 
share the property of Ca2+-dependent nuclear translocation and a fifth member, 
NFAT5, which is Ca2+-independent and shares limited homology with the other 
family members.  
 NFAT activity has been shown to contribute to the maintenance of the 
differentiated smooth muscle phenotype through regulation of 1 integrin and 
caldesmon expression (Ohkawa et al., 2003) and has been implicated in 
regulating the expression of the SM MHC gene (Wada et al., 2002). More 
recently, NFAT has been proposed to regulate the expression of the KV2.1 
voltage-dependent potassium channel in SMCs and thereby regulate arterial 
smooth muscle excitability (Amberg et al., 2004). A number of transcription 
factors that play a role in regulating SMC-specific gene expression are known to 
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act as NFAT cofactors, including Egr-1, AP-1, YY1, the MADS family member 
MEF2, and members of the GATA family (Kumar & Owens, 2003) and the 
references therein). Using intact cerebral artery preparations, we have recently 
found that the NFATc3 isoform exhibits nitric oxide/protein kinase G-dependent 
nuclear localization in vascular smooth muscle cells in response to a 
normotensive pressure stimulus (Gonzalez Bosc et al., 2004). The implication is 
that NFATc3 is constitutively nuclear and potentially active under normal 
physiological pressure and may thereby provide a link to the postulated role for 
protein kinase G in the phenotypic maintenance of differentiated smooth muscle 
(Lincoln et al., 2001).  
 Mack and Owens (Mack & Owens, 1999) have demonstrated that in the 
context of a construct containing 5’ CArG boxes A and B, exon 1, and intron 1, a 
double mutation in the α-actin intronic CArG box that disrupts SRF binding also 
disrupts normal SMC-specific expression, decreasing reporter activity in vitro and 
in vivo.By sequence analysis, we have identified a highly conserved NFAT 
binding site that overlaps this intronic SRF binding site. Intriguingly, the CArG box 
mutations that had been shown to disrupt SMC-specific expression also resulted 
in disruption of the overlapping NFAT site. The individual contributions of SRF 
and NFAT to enhancer activity have not been experimentally tested. Here we 
show that a 56-bp α-actin intronic element that contains conserved SRF, NFAT 
and AP-1 binding sites is capable of acting as an enhancer element, increasing 
the basal activity of a minimal promoter-reporter construct in both SMCs and 
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HEK293 cells and conferring responsiveness to NFAT-activating stimuli in 
HEK293 cells. Mutations that independently disrupt either the NFAT site or the 
SRF binding site are each capable of essentially eliminating basal activity in 
SMCs and inducible activity in HEK293 cells, suggesting that both SRF and 
NFAT are required for enhancer activity under these conditions. In support of the 
idea that SRF and NFAT cooperate to mediate enhancer activity, we found that 
both SRF and NFAT bind simultaneously to the overlapping CArG box/NFAT site 
in this conserved intronic regulatory element under conditions that are associated 
with enhancer activity. Finally, in vitro expression of α-actin in SMCs was 
decreased by inhibiting NFAT activation, suggesting that the molecular 
interaction of NFAT and SRF at the intronic enhancer element may be 
physiologically relevant.  
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EXPERIMENTAL PROCEDURES 
 
Cell Culture—The rat A7r5 aortic smooth muscle cell line and an HEK293 human 
embryonic kidney-derived cell line (BD Biosciences) were grown in Dulbecco’s 
modified Eagle’s medium (Invitrogen) containing 10% fetal bovine serum and 
penicillin-streptomycin (10 units/ml; Invitrogen). G418 (2 mg/ml) was included in 
cultures of this reverse tetracycline transactivator (rtTA)-expressing HEK293 
derivative (used in experiments involving co-transfection of a Tet operator-EGFP-
NFATc3 construct) to maintain stable rtTA expression. The cultures were 
maintained in a humidified incubator at 37 °C and 5% CO2.  
 
Construction of Plasmids—A 56-bp region of the α-actin first intron 
(corresponding to nucleotides 1035–1090 in GenBankTM accession number 
U63129 [GenBank] ) containing a previously identified SRF-binding CArG box, an 
overlapping NFAT binding motif, and an AP-1 binding site, designated SNAP 
(SRF/NFAT/AP-1), was used as a starting point in the design of reporter 
constructs (see Fig. 1). A double-stranded oligonucleotide covering this region 
was prepared by combining equimolar amounts of single-stranded sense and 
antisense oligonucleotides (IDX Technologies), heat denaturing (95 °C, 5 min), 
and allowing them to slowly anneal at room temperature. SNAP oligonucleotides, 
synthesized to contain NheI sites at each end (61 bp, total length), were cloned 
into an NheI site present in the multi-cloning region of a luciferase reporter 
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plasmid containing a minimal thymidine kinase (TK) promoter (pTAL; BD 
Biosciences). After transforming competent Escherichia coli (Invitrogen) and 
preparing DNA minipreps from isolated colonies (Qiagen), individual clones were 
screened by restriction analysis to determine the number of inserted copies and 
then sequenced to determine the orientation of each insert. Reporter constructs 
containing mutations in the NFAT (AGGTTT), SRF (AATAATTAGG), or AP-1 
(TCATACA) binding sites were similarly prepared.  
 Full-length NFATc3 was prepared from a plasmid (pSH205A) containing 
an alternatively spliced murine NFATc3 cDNA (37) kindly provided by Dr. Gerald 
Crabtree. The N terminus of native NFATc3 was amplified from mouse smooth 
muscle total RNA by reverse transcription-PCR and ligated into an XbaI site 
defining the 5’ end of the NFATc3 cDNA. A Tet-operated EGFP-NFATc3 fusion 
protein expression plasmid (pTetOP-EGFP-NFATc3-HGHpA) was prepared by 
cloning full-length NFATc3 into a pTetOP-EGFP-HGHpA plasmid constructed 
from pTetOP-HGHpA (containing a Tet operator and human growth hormone 
poly(A) tail) (38) and pEGFP-C3 (Clontech).  
 
Transient Transfection and Luciferase Assay—HEK293 cells were transfected 
with TK-luciferase reporter constructs containing one, two, or three tandem 
copies of the SNAP element in the all-forward or all-reverse orientation using the 
FuGENE 6 transfection reagent (3:1 ratio of transfection reagent (µl)/total plasmid 
DNA (µg)) according to the manufacturer’s protocol (Roche Applied Science). 
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Luciferase activity in cell lysates was determined using the Luciferase Assay 
System according the manufacturer’s protocol (Promega) and expressed relative 
to empty pTAL vector controls. Luciferase activity was normalized to protein 
concentration.  
 A7r5 cells were co-transfected with wild-type or mutant SNAP reporter 
constructs or pTAL empty vector and pRL-TK (Renilla expression plasmid; 
Promega) using Superfect transfection reagent (10 µl reagent/2 µg total 
DNA/well) according to the manufacturer’s protocol (Qiagen). Luciferase and 
Renilla activity were simultaneously detected (Dual-Luciferase Reporter Assay 
System; Promega); Renilla activity was used to normalize luciferase activity.  
In some experiments, exogenously expressed EGFP-NFATc3 was used to 
monitor NFAT subcellular localization and transfection efficiency. For 
experiments employing HEK293 cells, an HEK293 derivative stably expressing 
rtTA was co-transfected with TetOP-EGFP-NFATc3 and cultured in the presence 
of doxocyclin (2 µg/ml) to induce EGFP-NFATc3 expression. A7r5 cells were also 
co-transfected with an rtTA expression plasmid, but were otherwise treated the 
same as HEK293 cells.  
 
Whole-cell Extracts—After trypsinization, cells were washed three times in PBS, 
resuspended in lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 
mM dithiothreitol, and 1% Nonidet P-40) containing protease inhibitors (0.5 mM 
phenylmethylsulfonyl fluoride, 5 µg/ml aprotinin, 9 µg/ml leupeptin, and 10 µg/ml 
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pepstatin), and incubated for 30 min on ice. Lysates were cleared by 
centrifugation at 14,000 rpm for 5 min at 4 °C, and the supernatants were 
assayed for protein content using the Bradford assay with bovine serum albumin 
as the protein standard. Aliquots were stored at –80 °C prior to use. Whole-cell 
extracts, containing a mixture of phosphorylated (primarily cytoplasmic) and 
dephosphorylated (primarily nuclear) NFAT, are a convenient source of material 
for DNA binding assays (below) because only the calcineurin-activated, 
dephosphorylated form exhibits significant DNA binding competence.  
 
Avidin Biotin Conjugated DNA Binding (ABCD) Assay—Binding of SRF and/or 
NFAT to the SNAP element was determined using cellular extracts and biotin-
conjugated nucleotide probes/streptavidin-coated agarose beads in a 
modification of the DNA-protein binding assay developed previously by Wu and 
co-workers (39, 40). For each binding assay, whole-cell extracts containing 500 
µg of protein were incubated with 400 ng of biotinylated oligonucleotide probes in 
binding buffer (20 mM Tris, pH 8.0, 1 mM EDTA, 100 mM NaCl, 0.5% Nonidet P-
40, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 5 µg/ml aprotinin, 9 
µg/ml leupeptin, 10 µg/ml pepstatin, and 10 mM sodium molybdate) for 30 min on 
ice. Streptavidin-conjugated agarose beads (Pierce) were added (25 µl of a 50% 
slurry), and the suspensions were placed on a gyrating shaker platform at 4 °C 
for 1–3 h. The beads were pelleted by centrifugation at 9000 x g (4 °C), washed 
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three times in binding buffer, and eluted in 2x SDS loading buffer for SDS-PAGE 
and Western analysis.  
 
Co-immunoprecipitation—Whole-cell lysates from HEK293 cells (500 µg total 
protein content/sample, treated as described in the text) were incubated with 500 
ng of mouse anti-NFATc3-agarose conjugate (Santa Cruz Biotechnology) in 
DNA-protein binding buffer for 24 h at 4 °C with constant rocking in the presence 
or absence of unlabeled SNAP oligonucleotide. The beads were pelleted by 
centrifugation (2000 x g at 4 °C for 5 min), and the pellet was washed three times 
in a buffer consisting of 10 mM Hepes, pH 7.5, 150 mM NaCl, and 0.1% Nonidet 
P-40. After the third wash, the pellet was resuspended in SDS-loading buffer and 
boiled for 5 min at 95 °C. The proteins were separated by SDS-PAGE, 
transferred to nitrocellulose, and probed for SRF or NFATc3 by Western blotting. 
The absence of nonspecific binding to NFATc3-agarose beads was confirmed by 
stripping and reprobing for glyceraldehyde-3-phosphate dehydrogenase (primary 
antibody from Chemicon International; 1:1000 dilution for 1 h at room 
temperature; data not shown).  
 
Western Blot Analysis—Protein samples were separated by SDS-PAGE using 
7.5% acrylamide gels (Bio-Rad) in standard Laemmli buffer and transferred to 
nitrocellulose membranes (Bio-Rad). After blocking for 1 h at room temperature in 
Tris-buffered saline containing 5% nonfat milk and 0.1% Tween 20, blots were 
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exposed to primary antibodies (diluted in blocking solution) overnight at 4 °C or 
for 1 h at room temperature. The primary antibodies used were mouse 
monoclonal NFATc3 (1:200; Santa Cruz Biotechnology) and rabbit polyclonal 
SRF (1:4000; Santa Cruz Biotechnology). After multiple washes in Tris-buffered 
saline, horseradish peroxidase-conjugated secondary antibody (from Santa Cruz 
Biotechnology (1:10,000) or Pierce (1:2000) in blocking solution) was applied for 
1 h at room temperature. Bands were visualized using standard or high sensitivity 
chemiluminescence detection systems (Pierce Supersignal West Dura or Femto, 
respectively).  
 
Immunofluorescence—HEK293 and A7r5 cells were grown in an 8-well Lab-Tek 
chamber slide (Nalge Nunc). Cells were fixed with 4% formaldehyde in PBS for 
15 min, permeabilized in 0.1% Triton in PBS for 10 min, and then blocked in 3% 
donkey serum in PBS for 1 h. Primary antibody (rabbit polyclonal anti-NFATc3, 
1:100; Santa Cruz Biotechnology) was prepared in 0.1% gelatin in PBS and 
applied overnight at 4 °C. Secondary antibody (anti-rabbit Cy5, 1:500; Jackson 
Immunoresearch Laboratories) was prepared in 0.1% gelatin in PBS and applied 
for 1 h at room temperature. Nuclei were stained using SYTOX green (1:5000 in 
PBS).  
 Cells were examined at x40 magnification using a Bio-Rad 1000 laser 
scanning confocal microscope. NFAT and nuclear staining were detected by 
sequentially monitoring the Cy5 and SYTOX fluorescence using excitation 
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wavelengths of 650 and 488 nm and emission wavelengths of 670 and 520 nm, 
respectively. Specificity of immune staining was confirmed by the absence of 
fluorescence in cells incubated with secondary antibody alone. For scoring of 
NFAT-positive nuclei, multiple fields for each replicate of each experimental 
condition were imaged and counted by two independent observers under double-
blind conditions with the aid of Metamorph software (Universal Imaging Corp). 
The software was programmed so that individual pixels within a given image 
would appear white if co-localization of the green nucleic acid stain and the Cy5-
NFAT stain occurred. Thus, for quantification purposes, a cell was considered 
positive if co-localization (white) was distributed throughout the nucleus, whereas 
a cell was considered negative if no co-localization (green only) or only isolated 
co-localization was observed.  
 
In-cell Western Analysis—SM α-actin expression in SMCs was quantified using 
an infrared-based in-cell Western assay system as described by the 
manufacturer (Li-Cor Biosciences). Briefly, confluent cultures of A7r5 cells were 
trypsinized and seeded into 96-well plates (70% confluence). After 48 h in 1% 
fetal bovine serum, cells were treated as described in the text, washed once with 
PBS, fixed with 4% formaldehyde in PBS for 15 min at room temperature, and 
blocked (Aqua Block with 0.1% Tween 20). Primary antibody (mouse monoclonal 
anti-SM α-actin (1:250; Biogenex) or mouse monoclonal anti-α-actin (1:200; 
Sigma)) was applied overnight at 4 °C, followed by secondary antibody (goat anti-
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mouse IRDye 800 (1:800 dilution in Aqua Block with 0.1% Tween 20; Rockland)) 
for 1 h. TOTO-3 (1:1000; Molecular Probes) was used to counterstain DNA. 
Infrared fluorescence was monitored using an Odyssey Imager (700 nm for 
TOTO-3 and 800 nm for IRDye 800). The intensity of both channels was set at 
7.5, with a focus setting of 3 mm. Integrated intensity of SM α-actin or β-actin 
(housekeeping protein) stain was normalized to the integrated intensity of DNA 
stain. Because of the ease and accuracy with which multiple individual replicates 
can be independently analyzed, this approach is especially useful where 
quantitation is the goal.  
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RESULTS 
 
A CArG Box-containing Region of the Mouse α-Actin First Intron Acts as an 
NFAT- and SRF-dependent Enhancer Element—We have identified a putative 
NFAT binding site in the α-actin first intron that overlaps a functionally important 
SRF-binding CArG box (Mack & Owens, 1999). The sequence of this SRF-NFAT 
binding site-containing region is remarkably conserved among rodent, human, 
and chicken α-actin and includes a completely conserved AP-1 site at a position 
24 bp downstream of the NFAT site (Fig. 1). To test these putative binding sites 
for potential enhancer activity, an oligonucleotide encompassing this mouse -
actin first intronic region containing SRF, NFAT, and AP-1 binding sites (SNAP) 
was cloned into a luciferase reporter plasmid upstream of a minimal TK promoter. 
Constructs containing one, two, or three tandem copies of SNAP in either forward 
or reverse orientation were tested in HEK293 cells and SMCs for luciferase 
expression. The minimal TK promoter-luciferase construct containing three 
tandem copies of the insert in the reverse orientation showed the highest reporter 
activity of those constructs tested (data not shown) and was used in subsequent 
experiments. The wild-type reporter construct (SNAP-Luc) and variants 
containing mutated SRF (SmutNAP-Luc), NFAT (SNmutAP-Luc), or AP-1 (SNAPmut-
Luc) binding sites are depicted schematically in Fig. 2A.  
 Fig. 2, B and C, shows luciferase activity, normalized to the minimal TK 
promoter-containing (empty) pTAL vector, in SNAP-Luc-transfected SMCs and 
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HEK293 cells, respectively. In both cell lines, the SNAP element promoted a 
significant increase in reporter activity under basal (unstimulated) conditions, 
demonstrating that this small region of the mouse α-actin first intron is capable of 
acting as a functional enhancer element. Inhibition of the calcineurin/NFAT 
pathway with FK506 (1 µM) and CsA (1 µM) significantly decreased reporter 
activity in SNAP-Luc-transfected SMCs (Fig. 2B), suggesting NFAT involvement.  
To determine the relative contribution of SRF, NFAT, and/or AP-1 sites to the 
enhanced reporter activity, HEK293 cells and SMCs were transfected with SNAP-
Luc constructs containing mutations at each of these sites, designed such that 
mutations in one binding element were independent of each of the other binding 
elements. Mutating either the NFAT site (SNmutAPLuc) or the SRF binding site 
(SmutNAP-Luc) almost completely abolished basal enhancer activity in SMCs, 
suggesting that both NFAT and SRF binding sites were required for this activity 
(Fig. 2B). Mutating the AP-1 binding site (SNAPmut-Luc) partially decreased basal 
activity in SMCs (Fig. 2B), suggesting that full activity may require formation of an 
SRF·NFAT·AP-1 complex. In contrast, only SRF binding appears to be required 
for basal activity in HEK293 cells because a mutation in the CArG box alone 
(SmutNAP-Luc) abrogated enhancer activity, whereas a construct containing a 
mutated NFAT site (SNmutAP-Luc) or a mutated AP-1 site (SNAPmut-Luc) retained 
full basal activity (Fig. 2C).  
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NFAT/AP-1 Pathway Stimulation Increases SNAP Enhancer Activity in HEK293 
Cells—Concurrent treatment with the Ca2+ ionophore, ionomycin (Io), and 
phorbol 12-myristate 13-acetate acetate (PMA) is a stimulus paradigm that is 
commonly used to simultaneously activate NFAT and NFAT cofactor pathways 
(Liu et al., 1991; Chen et al., 1998; Macian et al., 2001). Dephosphorylation by 
the Ca2+-dependent phosphatase, calcineurin, serves to promote both NFAT 
nuclear accumulation and DNA binding (Neal & Clipstone, 2001). Stimulation of 
SNAP-Luc-transfected HEK293 cells with Io (1 µM) and PMA (100 nM) induced 
an ~4-fold increase in luciferase activity over unstimulated conditions (Fig. 3). 
This inducible luciferase activity was significantly inhibited by pre-treatment with 
the calcineurin inhibitors CsA and FK506, suggesting that dephosphorylation-
dependent translocation of NFAT from the cytosol to the nucleus contributes to 
the observed increase in activity. The Io/PMA-induced increase in reporter 
activity, like the basal enhancer activity in SMCs, was dependent on the integrity 
of both SRF and NFAT binding sites, as indicated by the virtual absence of 
inducible activity in HEK293 cells transfected with reporter constructs containing 
mutations in the NFAT (SNmutAP-Luc) or SRF (SmutNAP-Luc) sites. Similar to 
results obtained under basal conditions in SMCs, a mutation in the AP-1 site 
(SNAPmut-Luc) partially but significantly reduced the response to Io/PMA 
stimulation in HEK293 cells. Interestingly, the high basal activity of the SNAP-Luc 
construct in SMCs (~8-fold higher than that in similarly transfected HEK293 cells) 
86
 
cannot be further enhanced by treatment with Io/PMA (data not shown; see 
“Discussion”).  
 
NFATc3 and SRF Simultaneously Bind to the SNAP Enhancer Element—
Functional effects of individual site mutations on SNAP enhancer activity strongly 
suggest that NFAT and SRF bind simultaneously at overlapping SRF and NFAT 
sites within the α-actin intronic regulatory element under study. To determine 
whether this was the case, we performed ABCD assays to pull down SNAP-
associated proteins from cellular extracts, followed by Western analysis. Fig. 4A 
shows a representative ABCD assay employing whole-cell lysates from non-
stimulated and Io/PMA-stimulated HEK293 cells. Consistent with the functional 
data, only SRF was bound to the oligonucleotide probe under non-stimulated 
conditions (Fig. 4A, lane 1). Under stimulated conditions, both SRF and NFATc3 
were present in the DNA·protein complex (Fig. 4A, lane 2). Thus, the overlapping 
CArG box/NFAT site in the α-actin first intron can bind both NFATc3 and SRF in 
response to an NFAT-activating stimulus.  
 In competition assays employing either HEK293 or SMC whole-cell 
lysates, SRF binding to biotinylated SNAP was abrogated in the presence of an 
excess of unlabeled wild-type SNAP oligonucleotides. Unlabeled probes 
containing a scrambled sequence or a mutation in the SRF binding site 
(SmutNAP), however, failed to compete for SRF binding, demonstrating that the 
observed binding is sequence-specific (Fig. 4, B and C). To rule out the 
87
 
possibility that mutations in the adjacent NFAT or AP-1 sites might disrupt SRF 
binding, even though they do not disrupt the CArG site itself, we performed 
competition binding assays using unlabeled SNAP containing mutated NFAT 
(SNmutAP) or AP-1 (SNAPmut) binding sites. In each case, an excess of unlabeled 
oligonucleotides was able to prevent SRF binding to the labeled probe, indicating 
that an intact CArG box alone is sufficient to bind SRF.  
 These experiments do not rule out the formal possibility that NFATc3 and 
SRF are binding individually to separate populations of probe molecules rather 
than binding simultaneously to the same probe. To address this, we 
immunoprecipitated NFATc3 in the presence or absence of unlabeled SNAP 
oligonucleotide and probed for associated SRF by Western analysis (Fig. 5). 
Under standard detection conditions (Fig. 5A), a strong SRF band is evident in 
the presence of the SNAP probe (lane 1), whereas no SRF band is evident in the 
absence of SNAP (scrambled oligonucleotide, lane 2; no oligonucleotide, lane 3). 
By increasing the gain (i.e. using a higher sensitivity chemiluminescence 
detection system), we are able to show that SRF is present in NFATc3 
immunoprecipitates in the absence of SNAP, albeit to a lesser extent (Fig. 5B). 
These results indicate that SNAP acts as a sequence-specific scaffold to facilitate 
NFATc3 and SRF interactions, but they also suggest that NFATc3 and SRF may 
interact in solution.  
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NFATc3 Exhibits Constitutive Nuclear Localization in A7r5 Cells but Not HEK293 
Cells—In general, NFAT is localized to the cytosol of unstimulated cells. 
However, in the A7r5 cells used in this study, we found that in an overwhelming 
majority of cells (95.33 ± 2.53%, n = 3 images (81 cells)), endogenous NFATc3 is 
constitutively localized to the nucleus under basal conditions (Fig. 6A, right 
panel). Inhibition of calcineurin activity by treatment with CsA and FK506 (15 min) 
induced a substantial redistribution of nuclear NFATc3 to the cytoplasm (NFATc3-
positive nuclei = 27.40 ± 7.40%, n = 3 images (43 cells); p < 0.001 versus basal). 
Overexpressed EGFP-NFATc3 also exhibits nuclear localization in SMCs in the 
absence of an NFAT-activating stimulus (Fig. 6B, right panel). This distribution is 
strikingly different from the primarily cytosolic and perinuclear localization of both 
endogenous (Fig. 6A, left panel) and exogenously expressed (Fig. 6B, left panel) 
NFATc3 in HEK293 cells. These results are consistent with both the elevated 
basal activity of SNAP-Luc in SMCs and the requirement for an NFAT-activating 
stimulus for maximal reporter activity in HEK293 cells.  
 
Calcineurin/NFAT Pathway Inhibition Reduces α-Actin Expression in Smooth 
Muscle Cells—The fact that NFAT and SRF can simultaneously bind to a 
CArG/NFAT site corresponding to a region of the α-actin intron known to be 
important for regulating SMC-specific α-actin expression (Shimizu et al., 1995; 
Mack & Owens, 1999) suggests that NFAT cooperates with SRF in the regulation 
of α-actin expression. To confirm that the calcineurin/NFAT pathway is involved 
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in regulating the expression of SM α-actin, we treated confluent, serum-deprived 
A7r5 SMCs with the calcineurin inhibitors FK506 and CsA, and we measured 
changes in SM α-actin protein expression by in-cell Western analysis (see 
“Experimental Procedures”). Results are expressed relative to β-actin, and 
expression of both proteins was normalized to DNA content. Fig. 7 shows that 
inhibition of NFAT activation significantly decreased SM α-actin expression, 
reducing protein levels by nearly 50% compared with untreated controls. These 
results suggest that the NFAT-dependent regulation of SNAP enhancer activity, 
described above, is relevant to the regulation of α-actin expression.  
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DISCUSSION 
 
 We have found that a 56-bp region of the mouse SM α-actin first intron 
that contains a highly conserved SRF/NFAT/AP-1 (SNAP) composite binding site 
sequence is capable of acting as an enhancer element, increasing reporter 
activity in the context of a minimal TK promoter. These results are consistent with 
a previous report showing that a larger (180-bp) segment of the corresponding 
region of the human α-actin first intron, cloned upstream or downstream of a 
minimal SV40 promoter, exhibits enhancer activity (Nakano et al., 1991) and 
further support more recent results showing that the corresponding intronic region 
of the rat α-actin gene is required for robust in vitro and in vivo reporter 
expression in the context of a construct that includes 5’-regulatory elements and 
the first exon (Mack & Owens, 1999). More importantly, our results indicate that 
the previously unrecognized NFAT site and the overlapping SRF-binding CArG 
element are both absolutely required for the elevated basal activity in SMCs and 
induced activity in HEK293 cells. The SNAP region simultaneously binds both 
SRF and NFAT in HEK293 cells under conditions in which activity is induced but 
binds only SRF in the absence of stimulation, providing the first evidence that 
NFAT and SRF may interact to cooperatively regulate gene expression. Our 
results also show that inhibition of the calcineurin/NFAT pathway decreases α-
actin expression in SMCs, consistent with a role for NFAT in the regulation of α-
actin transcription.  
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 In HEK293 cells transfected with the SNAP-Luc construct, reporter 
expression in the absence of stimulation was significantly increased over that in 
cells transfected with a control luciferase reporter plasmid containing only a 
minimal TK promoter. The basal level of expression in HEK293 cells, however, 
was ~8-fold lower than that in SNAP-Luc-transfected SMCs, consistent with a 
potential SMC-selective role for this element. Basal expression in HEK293 cells 
was sensitive to disruption of the CArG box but unaffected by mutations in the 
NFAT site or the AP-1 site. This is in sharp contrast to Io/PMA-stimulated 
HEK293 cells (or unstimulated SMCs), in which mutations in NFAT or SRF sites 
were equally effective in abrogating reporter activity and a mutation to the AP-1 
site partially inhibited activity. Thus, in non-smooth muscle HEK293 cells, SRF 
alone appears capable of mediating a low basal level of transcription from the 
SNAP enhancer element, whereas the induced activity in these cells and the 
much higher basal activity in SMCs require both NFAT and SRF.  
 Interestingly, in SMCs, stimulation of the calcineurin/NFAT pathway with 
Io/PMA failed to increase the reporter activity of the SNAP-Luc construct beyond 
the already elevated basal level. The absence of inducible activity in SNAP-Luc-
transfected SMCs, as well as the profound difference in basal enhancer activity 
between SMCs and HEK293 cells, may be partially accounted for by differences 
in the subcellular distribution of the NFATc3 isoform between these two cell 
types. Although NFAT is normally presumed to localize to the cytosol of 
unstimulated cells, we found that a preponderance of endogenous as well as 
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exogenously expressed NFATc3 is constitutively localized to the nucleus of A7r5 
cells. In HEK293 cells, both endogenous and exogenously expressed NFATc3 is 
localized to the cytosol under basal conditions. Thus, a virtual absence of nuclear 
NFATc3 in unstimulated HEK293 cells is associated with low level, NFAT-
independent SNAP enhancer activity. Stimulation of HEK293 cells with Io/PMA 
increases nuclear NFATc3 (data not shown) and SNAP enhancer activity. In 
SMCs, in which NFATc3 is constitutively nuclear, SNAP activity is high, NFAT-
dependent, and unresponsive to Io/PMA treatment. Although these results do not 
necessarily indicate that SNAP preferentially binds the NFATc3 isoform, they are 
consistent with the interpretation that sufficient nuclear NFAT in the form of 
NFATc3 is present in SMCs to drive maximal enhancer activity under basal 
conditions.  
 The constitutively nuclear NFATc3 observed in SMCs is redistributed to 
the cytosol following inhibition of calcineurin with FK506 and CsA (Fig. 6C). This 
result suggests that NFAT import mechanisms may be constitutively elevated in 
these cultured SMCs, an observation that could be explained by elevated 
calcineurin activity. Alternatively, mechanisms that act to promote nuclear export 
may be less active under basal conditions. Recent work from our laboratory has 
shown that regulation of NFATc3 nuclear export may be central to the activation 
state of NFAT in smooth muscle (reviewed in (Hill-Eubanks et al., 2003). In 
unpressurized arteries, basal NFATc3 nuclear export is high as a result of 
elevated JNK2-mediated export; stimuli that induce a net nuclear accumulation of 
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NFATc3 are those that not only elevate intracellular Ca2+ but also result in a 
decrease in JNK2-mediated export (Gomez et al., 2003). In response to a 
normotensive pressure stimulus, JNK2 activity in native smooth muscle is 
reduced via a nitric oxide/protein kinase G-dependent pathway, and NFATc3 is 
predominantly localized to the nucleus (Gonzalez Bosc et al., 2004). In this 
respect, A7r5 may exist in a state similar to that of pressurized arteries, with 
reduced JNK2-mediated export activity and constitutively nuclear NFATc3.  
SMCs are known to express higher levels of SRF than other cell types (Tuil et al., 
1990; Chang et al., 2001), so it is conceivable that the difference between the 
levels of basal and induced enhancer activity between SMCs and HEK293 cells 
may also reflect limiting SRF levels in HEK293 cells. Although HEK293 cells do 
contain sufficient SRF to drive low basal levels of enhancer activity and to detect 
in a complex with the SNAP element, it may be that higher levels of SRF are 
required for efficient recruitment of NFAT and maximal enhancer activity.  
 Our reporter assay data showing that basal SNAP enhancer activity in 
SMCs and induced activity in HEK293 cells are dependent on both intact SRF 
and NFAT sites suggest a cooperative mechanism of action between SRF and 
NFAT. This idea is supported by the binding of both NFATc3 and SRF to the 
SNAP element under conditions in which the NFAT pathway is activated in 
HEK293 cells. The presence of SRF in NFATc3 immunoprecipitates provides 
compelling evidence that SRF and NFATc3 interact. The fact that associated SRF 
is increased in the presence of SNAP is most consistent with the interpretation 
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that simultaneous binding of SRF and NFATc3 to their respective sites facilitates 
NFATc3/SRF interactions. SRF binding alone is insufficient to promote enhancer 
activity under NFAT stimulated conditions because a mutation at the NFAT 
binding site does not substantially inhibit SRF binding to the overlapping CArG 
box but almost completely abrogates induced reporter activity.  
 SRF, a member of the MADS family of transcription factors (Shore & 
Sharrocks, 1995), has been shown to bind to the REL homology domain of 
nuclear factor-κB (Franzoso et al., 1996) to enhance nuclear factor-κB 
transcriptional activity. NFAT, which also contains a REL homology domain, has 
been previously shown to functionally interact with the MADS family member 
Mef2 (Chin et al., 1998). This is the first report, however, to suggest that NFAT 
and SRF may interact with one another to function as transcriptional co-
activators. The SRF and NFAT domains that may be responsible for mediating 
protein-protein interactions in the putative SRF·NFAT complex, as well as the role 
that the individual NFAT and/or SRF transactivation domains may play in 
mediating interactions with the transcriptional machinery, are currently unknown. 
Our data also suggest that AP-1, which is a common NFAT cofactor (Macian et 
al., 2001) that has also been implicated in SRF signaling (Paradis et al., 1996), 
contributes to NFAT/SRF enhancer efficacy, although the molecular details of this 
involvement remain to be defined.  
 SRF has been previously shown to interact with other transcription factors, 
such as ETS domain-containing transcription factors (e.g. Elk-1), the 
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homeodomain proteins Barx1b and Nkx3.2, and the zinc finger protein GATA6 
(Kumar & Owens, 2003). In smooth muscle, the transcription factor myocardin 
has been shown to regulate SRF-dependent transcription of a –2.6/+2.8-kb α-
actin promoter/intronic construct through interactions that exhibit a combinatorial 
dependence on CArG elements, primarily involving CArG B and CArG A boxes 
(Yoshida et al., 2003). The apparent preferential interaction of myocardin with 
proximal promoter CArG boxes suggests that NFAT action at the intronic SNAP 
element may operate in parallel with myocardin activity, with both pathways 
required for full transcriptional activity. Considered in the context of the 
demonstrated Ca2+ dependence of smooth muscle differentiation marker gene 
expression (Wamhoff et al., 2004), it is possible that the NFAT pathway may 
contribute to the Ca2+ sensitivity component of SMC gene expression, serving to 
integrate Ca2+ signals at regulatory elements of smooth muscle-specific genes, 
including α-actin.  
 In addition to the molecular evidence supporting a role for NFAT in the 
regulation of α-actin expression, this study shows that inhibition of the 
calcineurin/NFAT pathway in cultured rat SMCs decreases α-actin protein 
expression. This result is in accord with a recent report showing that blockade of 
calcineurin/NFAT in primary cultures of human vascular smooth muscle is 
associated with a reduction in both α-actin and SM MHC protein expression 
(Amberg et al., 2004). Another recent study has also implicated NFAT in the 
regulation of α1 integrin and caldesmon expression in cultured visceral SMCs, 
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showing that calcineurin activity is required for the expression of these smooth 
muscle markers and maintenance of the contractile smooth muscle phenotype 
(Ohkawa et al., 2003). The proposed interactions between NFAT and SRF at the 
α-actin intronic composite binding site may provide a molecular framework to 
help explain the apparent NFAT dependence of α-actin expression in SMCs, but 
it appears unlikely that this interaction can be invoked as a general mechanism to 
account for the NFAT dependence of other smooth muscle-specific genes. For 
example, although the regulation of SM MHC expression in smooth muscle 
exhibits similarities to that of α-actin regulation in that dual 5’ CArG boxes and an 
intronic CArG box are all required for smooth muscle-specific expression, neither 
the 5’ nor intronic CArG box is associated with NFAT binding sites. Instead, NFAT 
appears to regulate SM MHC expression through an association with GATA at 
unidentified sites in the 5’-flanking sequence of the SM MHC gene (Wada et al., 
2002). The single 5’-upstream CArG box of α1 integrin that is required for 
expression in differentiated SMCs (Obata et al., 1997) likewise lacks an 
associated NFAT site. In addition to the conserved intronic NFAT site 
characterized here, the first intron of α-actin is rich in potential NFAT binding 
sites, many of which are phylogenetically conserved and might be expected to 
contribute to NFAT-sensitive expression. To the extent that NFAT is involved in 
regulating the expression of SMC-specific genes, it is likely that it does so 
through multiple mechanisms involving interactions with different cofactors.  
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Figure 1. Region of the mouse α-actin gene containing 5' CArG boxes A 
and B, exon 1, and intron 1. The intronic SNAP element used in these studies 
is composed of an SRF binding element (CArG box), an overlapping NFAT 
binding site, and an AP-1 binding site shown in red, blue, and green, 
respectively. The CArG box and NFAT site are identical in mouse and rat; 
nucleotides in capital letters are completely conserved among chicken, mouse, 
and human. 
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Figure 2. A CArG box-containing region of the mouse α-actin first intron 
acts as an NFAT- and SRF-dependent enhancer under basal conditions. A, 
reporter constructs containing three tandem copies (depicted in forward 
orientation) of the SM α-actin first intronic enhancer element (SNAP) used in 
transfection experiments: wild-type (SNAP-Luc), NFAT-mutated (SNmutAP-Luc), 
SRF-mutated (SmutNAP), or AP-1-mutated (SNAPmut). B, A7r5 SMCs were 
transfected with the SNAP-Luc construct or its mutants, as described under 
"Experimental Procedures." Activity is expressed relative to the empty pTAL 
vector, which contains a minimal thymidine kinase promoter-luciferase 
expression cassette (TK-Luc). A subgroup of cells transfected with SNAP-Luc 
(wild-type) was pre-treated with 1 µM FK506 and 1 µM CsA. *, p < 0.001 versus 
all; n = 6–9. C, HEK293 cells were transfected with the SNAP-Luc wild-type and 
mutant constructs, as described. Luciferase activity was normalized to reporter 
activity of cells transfected with empty vector. *, p < 0.01 versus all; n = 6. 
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Figure 3. NFAT/AP-1 pathway stimulation increases SNAP reporter activity 
in HEK293 cells. HEK293 cells were transfected with wild-type SNAP-luciferase 
construct (SNAP-Luc) or constructs containing mutations in NFAT (SNmutAP-
Luc), SRF (SmutNAP-Luc), or AP-1 (SNAPmut-Luc) sites and incubated for 24 h 
with or without 1 µM Io and 100 nM PMA. HEK293 cells transfected with a 
minimal TK-Luc vector (pTAL/no insert) served as a control. Luciferase activity of 
each construct under stimulated conditions is expressed relative to reporter 
activity under non-stimulated conditions. Also shown is Io/PMA-stimulated SNAP-
Luc activity in the presence of 1 µM FK506 and 1 µM CsA expressed relative to 
unstimulated SNAP-Luc without FK506/CsA. *, p < 0.01 versus no insert + 
Io/PMA, FK506/CsA + Io/PMA, SNmutAP + Io/PMA, SmutNAP + Io/PMA, and 
SNAPmut + Io/PMA; #, p < 0.05 versus no insert + Io/PMA. n = 4–10. 
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Figure 4. ABCD assay showing NFAT and SRF binding to SNAP. A, whole-
cell lysates (500 µg of protein) from untreated HEK293 cells (Basal) or cells 
treated for 1 h with 1 µM ionomycin and 100 nM PMA (I/PMA) were incubated for 
30 min in the presence (lanes 1 and 2) or absence (lanes 3 and 4) of biotin-
labeled SNAP (Biotin-SNAPwt) probe. Streptavidin-agarose-conjugated beads 
were added and incubated for 2 h. Pellet eluted was separated by SDS-PAGE 
and blotted for NFATc3 or SRF. Lanes 5 and 6 contain 30 µg of whole-cell 
extract. B, whole-cell lysates (500 µg of protein) from Io/PMA-treated HEK293 
cells were pre-incubated for 30 min with non-labeled probe containing wild-type 
(SNAPwt), NFAT-mutated (SNmutAP), SRF-mutated (SmutNAP), AP-1-mutated 
(SNAPmut), or scrambled sequences (lanes 4–8). Lane 9 contains 30 µg of whole-
cell extract. C, A7r5 whole-cell lysates (500 µg of protein) were pre-incubated for 
30 min with non-labeled probe containing wild-type, mutated, or scrambled 
sequences (lanes 3–7). Lane 8 corresponds to 30 µg of whole-cell extract. 
Representative experiments of n = 3. 
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Figure 5. SNAP facilitates co-immunoprecipitation of SRF and NFAT. 
NFATc3 was immunoprecipitated from whole-cell lysates (500 µg of protein) of Io 
(1 µM)/PMA (100 nM)-treated (1 h) HEK293 cells in the presence or absence of 
SNAP followed by Western blotting for SRF using standard sensitivity (A) or high 
sensitivity (B) chemiluminescence detection systems (see "Experimental 
Procedures"). In C, Western blotting of NFATc3 immunoprecipitates for NFATc3 
demonstrates uniform loading and immunoprecipitation efficacy. Lane 1, SNAP 
oligonucleotide; lane 2, scrambled sequence oligonucleotide; lane 3, no 
oligonucleotide. 
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Figure 6. Differential subcellular localization of NFATc3 between HEK293 
and A7r5 cells. A, representative immunofluorescence confocal microscopic 
images of endogenous NFATc3 in HEK293 and A7r5 cells. White pixels 
represent co-localization of NFATc3 (red) and nuclei (SYTOX green staining). 
Scale bar represents 50 µm. B, EGFP fluorescence in EGFP-NFATc3-
transfected HEK293 and A7r5 cells monitored at 37 °C using 440DF20/480DF30 
excitation/emission filters (Lambda 10-2; Sutter Instruments, Novato, CA) with 
the aid of METAFLUOR 4.01 analysis software (Universal Imaging, Media, PA). 
EGFP-NFATc3 exhibits both nuclear and cytosolic localization in SMCs; HEK293 
cells show only cytosolic/perinuclear fluorescence. C, representative images of 
an A7r5 cell showing EGFP-NFATc3 nuclear expression before and 15 min after 
treatment with 1 µM FK506 and 1 µM CsA at 37 °C. Inset images correspond to 
endogenous NFATc3 expression detected by immunofluorescence in A7r5 cells 
under the same treatment conditions. 
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Figure 7. Calcineurin/NFAT pathway inhibition reduces α-actin expression 
in aorta-derived smooth muscle cells (A7r5). Cells were seeded in 96-well 
plates and grown in Dulbecco's modified Eagle's medium/10% fetal bovine 
serum. After 24 h, medium was changed to Dulbecco's modified Eagle's 
medium/1% fetal bovine serum in the absence (Control) or presence of 1 µM 
FK506 and 1 µM CsA (FK + CsA) for 48 h. SM α-actin and α-actin were detected 
by in-cell Western blot (Odyssey Technology). Results are expressed as the ratio 
of integrated α-or β-actin staining intensity to integrated intensity of DNA staining. 
*, p < 0.0001 (n = 48). NS, non-significant (n = 18). 
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 ABSTRACT 
 
 The nuclear factor of activated T-cells (NFAT) is a calcium (Ca2+)-dependent 
transcription factor that has been reported to regulate the expression of smooth 
muscle contractile proteins and ion channels. Here we report that large 
conductance Ca2+-sensitive potassium (K+) (BK) channels and voltage-gated K+ 
(KV) channels may be regulatory targets of NFATc3 in urinary bladder smooth 
muscle (UBSM). UBSM myocytes from NFATc3-null mice displayed a reduction 
in iberiotoxin (IBTX)-sensitive BK currents (IBK), a decrease in mRNA for the 
pore-forming α-subunit of the BK channel, and a reduction in the BK channel 
density compared to myocytes from wild-type mice. TEA-sensitive KV currents 
(IKv) were elevated in UBSM myocytes from NFATc3-null mice, as was mRNA for 
the Shab family member, KV2.1. Despite the upregulation in KV current, bladder 
strips from NFATc3-null mice displayed an elevated contractile response to 
electrical field stimulation (EFS) relative to strips from wild-type mice, but this 
difference was abrogated in the presence of the BK channel blocker IBTX. These 
results support a role for the transcription factor NFATc3 in regulating UBSM 
contractility primarily through a downregulation of BK channel activity. 
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 INTRODUCTION 
 
 Urinary bladder smooth muscle (UBSM) exhibits spontaneous phasic 
contractions that are coordinated by neuronal activity to generate the force 
necessary to expel urine. These contractions are initiated by bursts of action 
potentials that individually consist of a depolarizing upstroke followed by a 
repolarizing phase and afterhyperpolarization (Brading, 1992; Hashitani et al., 
2001; Hashitani & Brading, 2003b). Calcium (Ca2+) influx through L-type voltage-
gated Ca2+ channels (L-VDCC) mediates the upstroke of the action potential 
(Heppner et al., 1997; Buckner et al., 2002; Hashitani & Brading, 2003b). 
Potassium (K+) efflux through two types of voltage-sensitive K+ channels, large-
conductance Ca2+-sensitive K+ (BK) channels  and voltage-gated K+ (KV), 
channels contributes to the repolarization phase of the action potential (Heppner 
et al., 1997; Hashitani & Brading, 2003b, a; Thorneloe & Nelson, 2003). In 
addition to their role in repolarization, KV channels, as well as small conductance, 
Ca2+-sensitive K+ (SK) channels, likely play a role in the afterhyperpolarization 
(Hashitani & Brading, 2003b; Thorneloe & Nelson, 2003). 
 BK channels in UBSM are composed of four pore-forming α-subunits and 
accessory β1-subunits (Garcia-Calvo et al., 1994; Knaus et al., 1994; Thorneloe 
& Nelson, 2005). The β1-subunit increases the apparent voltage- and Ca2+-
sensitivity of the BK α-subunits (Brenner et al., 2000; Cox & Aldrich, 2000; 
Petkov et al., 2001). Block of BK channels by the scorpion toxins iberiotoxin 
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 (IBTX) or charybdotoxin (CTX) increases the duration and peak amplitude of 
UBSM action potentials (Kaczorowski et al., 1996; Heppner et al., 1997), 
resulting in an increase in the force of muscle contraction (Herrera et al., 2000; 
Imai et al., 2001; Hashitani & Brading, 2003b, a). BK currents are absent in 
isolated UBSM myocytes from mice in which the pore-forming α-subunit of the 
BK channel has been deleted (Slo-/-) (Meredith et al., 2004). These mice display 
an increase in the frequency and amplitude of spontaneous phasic contractions, 
as well as a significantly elevated contractile response to EFS (~5-fold increase 
over wild-type at 20 Hz stimulation) and to direct muscarinic stimulation with 
carbachol (Thorneloe et al., 2005; Werner et al., 2007)  Slo-/- mice exhibit 
significantly elevated bladder pressures, an increase in the oscillations of the 
intravesicular pressure, reduced capacity, and a reduced volume per void 
(Thorneloe et al., 2005), which suggests that a decrease in BK channel activity 
may contribute to the symptoms associated with urinary bladder dysfunction. 
 Like BK channels, KV channels are comprised of four α-subunits arranged 
radially around a central pore (Jan & Jan, 1997; Yi et al., 2001; Yellen, 2002). 
The pore-forming α-subunits are encoded by a large family of genes that can 
combine to form channels with a broad range of biophysical and pharmacological 
properties. KV α-subunits from the KV1 - 4 subfamilies can form functional homo- 
or heteromultimeric complexes, while the electrically-silent KV family members 
(KV 5-11) cannot form functional channels alone but, rather, co-assemble with 
other KV family proteins to make ion channels with unique conductances (Post et 
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 al., 1996; Salinas et al., 1997a; Salinas et al., 1997b; Kramer et al., 1998; 
Martens et al., 1999; Thorneloe & Nelson, 2003).  
 We have previously evaluated the biophysical, pharmacological, and 
molecular properties of the murine UBSM KV current (Thorneloe & Nelson, 2003). 
The insensitivity of the mouse UBSM KV current to block by 4-aminopyridine (4-
AP) indicates that KV1 or KV4 subunits, which are known to be blocked by 
submillimolar concentrations of 4-AP (Fiset et al., 1997; Nerbonne, 2000), do not 
contribute to UBSM KV currents. However, the murine UBSM KV current is 
blocked by tetraethylammonium chloride (TEA) with an IC50 of 5.2 mM, which is 
consistent with the properties of KV2 and KV3 subunits (Nerbonne, 2000) . RT-
PCR analysis of UBSM tissue, combined with biophysical comparisons of the 
murine UBSM KV current to values reported in the literature for other KV channel 
complexes, suggests that the UBSM KV channel is most likely a heteromultimeric 
assemblage of KV2.1 subunits combined with KV5.1 and/or KV6.1 subunits 
(Thorneloe & Nelson, 2003). This stands in contrast to the KV currents of 
vascular smooth muscle, which are carried primarily by channels composed of 
members of the 4-AP-sensitive KV1 subfamily (Yuan et al., 1998; Thorneloe et 
al., 2001). 
 The activity of both BK and KV channels is subject to short term modulation 
by protein kinase activity (Robertson et al., 1993; Schubert et al., 1996; Schubert 
et al., 1999; Schubert & Nelson, 2001; Ledoux et al., 2006). However, it has also 
been recently reported that the expression of these channels can be modulated 
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 by Ca2+-dependent transcription factors, providing a link between K+ channel 
expression and alterations in Ca2+ signaling patterns. Specifically, the 
transcription factor NFAT (nuclear factor of activated T cells) has been reported 
to regulate the expression of KV2.1 channels in vascular smooth muscle tissue 
and in cardiac myocytes (Amberg et al., 2004; Rossow et al., 2004). In addition, it 
has been recently reported that NFAT also regulates the expression of the 
modulatory β1-subunit of the BK channel (Nieves-Cintron et al., 2006). 
 NFAT is a Ca2+-sensitive transcription factor that integrates Ca2+ signals with 
the activity of other signaling pathways, converting the information encoded in 
Ca2+ events into transcriptional responses (Rao et al., 1997; Crabtree, 1999; 
Crabtree & Olson, 2002; Hill-Eubanks et al., 2003; Hogan et al., 2003). NFAT 
activity is controlled primarily through regulation of its subcellular localization 
(Flanagan et al., 1991; Crabtree & Clipstone, 1994; Zhu & McKeon, 2000). Under 
non-stimulated conditions, the four Ca2+-sensitive members of the NFAT family 
(NFATc1-c4) are cytosolic phosphoproteins. Elevations in intracellular Ca2+ 
promote the nuclear localization of NFAT by activating the Ca2+- and calmodulin-
dependent protein phosphatase calcineurin, which dephosphorylates N-terminal 
NFAT serine residues, inducing a conformational change that exposes nuclear 
localization signals (Clipstone & Crabtree, 1992; Jain et al., 1992; Beals et al., 
1997; Rao et al., 1997; Okamura et al., 2000; Crabtree & Olson, 2002). Once in 
the nucleus, NFAT acts as a transcriptional co-regulator, associating with 
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 cofactors at composite regulatory elements to modulate the transcription of target 
genes (Rao et al., 1997; Crabtree & Olson, 2002; Im & Rao, 2004).  
 K+ channel expression and activity is a crucial factor in determining the 
contractile status of smooth muscle including UBSM. The fact that KV channels 
are putative regulatory targets of NFAT would, in turn, imply that NFAT 
transcriptional activity may modulate UBSM contractility. There are currently no 
reports of NFAT activity in UBSM, although stimulation of the calcineurin/NFAT 
pathway in UBSM myocytes by overexpressing a constitutively active form of 
calcineurin induces a hypertrophic phenotype (Nozaki et al., 2003), suggesting a 
possible role for NFAT activity in UBSM tissues. 
 The goal of the present study was to examine the role of NFAT in regulating 
UBSM contractility. We have found that murine UBSM expresses several NFAT 
isoforms (NFATc1, NFATc3, and NFATc4), and have chosen to focus on 
NFATc3 since it has been previously reported to modulate the expression of K+ 
channels and α-actin in smooth muscle (Amberg et al., 2004; Gonzalez Bosc et 
al., 2005; Nieves-Cintron et al., 2006). UBSM strips from NFATc3-null mice 
exhibit increased force generation in response to EFS as compared to strips from 
wild-type mice. We attribute the increased contractility of the UBSM from 
NFATc3-null mice to a downregulation in BK channel expression and activity, 
which would lead to increased excitability and contractility. Therefore, NFATc3 
may play important role in the regulation of UBSM contractility through regulation 
of the expression of BK channels. Furthermore, these results suggest that UBSM 
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 disorders, which are characterized by alterations in Ca2+ regulation, might reflect 
NFAT-mediated alterations in BK channel function.   
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 METHODS 
 
 Isolation of myocytes. Adult mice were euthanized with an overdose of 
pentobarbital, followed by exsanguination according to a protocol approved by 
the University of Vermont Office of Animal Care and Management. NFATc3-null 
mice, originally supplied by Dr. Laurie Glimcher, and the wild-type background 
strain mice (Balb/C) were used in all experiments. The bladders were removed 
and placed into an ice-cold Ca2+-free dissection solution (DS; 55 mM NaCl, 5.6 
mM KCl, 2 mM MgCl2, 80 mM sodium glutamate, 10mM glucose; buffered to pH 
7.3 with 10 mM Hepes). After the external fatty and connective tissues were 
removed, the bladders were cut open, rinsed free of urine, and the urothelial 
layer was carefully peeled away. The detrusor was cut into small sections 
(approximately 2 mm x 2 mm) and digested for 20-30 min in DS containing 1 
mg/mL Papain (Worthington, Lakewood, NJ, USA) with 1mg/mL dithioerythreitol 
(Sigma, St. Louis, MO, USA), rinsed briefly with DS, and then further digested in 
DS containing 1 mg/mL collagenase type II (Sigma, St. Louis, MO, USA) with 
100 µm CaCl2 for 6-10 min. Both digestions were performed at 37°C. The 
digested tissue sections were gently triturated using a fire-polished glass Pasteur 
pipette to release individual UBSM myocytes. 
 
 Electrophysiology. Whole cell currents were recorded using the perforated-
patch configuration of the whole-cell patch clamp technique. Aliquots of 
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 dissociated myocytes were transferred to a 0.5 mL electrophysiology chamber. 
After 15-20 min, the cells were thoroughly rinsed in a bath solution consisting of 
134 mM NaCl, 6 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose, 10 mM 
Hepes, pH 7.4. The pipette solution consisted of 110 mM potassium aspartate, 
10 mM NaCl, 30 mM KCl, 1 mM MgCl2, 0.05 mM EGTA, and 10 mM Hepes pH 
7.2. Amphotericin, initially solubilized in DMSO, was added to the pipette solution 
to a final concentration of 200 µg/mL. Iberiotoxin (IBTX; 100 nM final 
concentration) and tetraethylammonium chloride (TEA; 5 mM final concentration) 
were both purchased from Sigma and solubilized in the bath solution. 
 Single channel BK currents were recorded in excised inside-out patches 
using the patch-clamp technique. The patches were exposed to a 10 µM buffered 
Ca2+ solution. Single channel currents were recorded for to 2-5 min at potentials 
of -40 to + 40 mV at 22° C using pipettes fire polished to a final tip resistance of 
approximately 4 - 6 MΩ. The bath and pipette solution consisted of 140 mM KCl, 
1.8 mM MgCl2, 1 mM 5-hydroxyethylene-diaminetriacetic acid (HEDTA) and 0.13 
mM CaCl2 (10 µM free), adjusted to pH 7.2 with NaOH. Data were analyzed 
using pCLAMP software (Axon Instruments). The number of channels per patch 
was determined at a holding potential of + 60 mV. The open probability (Po) was 
determined by dividing the NPo, derived using the pCLAMP software, by the 
number of channels in the respective patch. 
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  UBSM contractility studies. Bladders were harvested and rinsed, and the 
urothelium was removed, as detailed above. Detrusor tissue strips (1 mm x 3 
mm), cut longitudinally from the dome to the bladder base, were suspended in 
jacketed waters baths (7 ml volume, 37°C) in an aerated bath solution (119 mM 
NaCl, 4.7 mM KCl, 24 mM NaHCO3, 1.2 mM KH2PO4, 2.5 mM CaCl2, 1.2 mM 
MgSO4, 0.023 mM EDTA, and 11 mM glucose). Contractility was measured after 
pre-stretching strips to 5 mN of tension for 45 min using a myograph (MyoMED, 
MED Associates, Inc.). The electrical field stimulation protocol consisted of 
sequential pulses from 0.5 to 50 Hz (20 volt pulse amplitude, 0.2 ms pulse width, 
2 sec pulse duration) at 3 minute intervals.  
 
 Immunohistochemistry and nuclear localization assay. Dissociated myocytes 
were placed into 8-well plates and the cells were allowed to adhere for 1 hour at 
37°C. The media was then replaced with growth media consisting of Dulbecco's 
modified Eagle's medium (Invitrogen) with 10% fetal bovine serum (Invitrogen, 
Carlsbad, CA, USA) and penicillin-streptomycin (10 units/mL, Invitrogen). The 
plates were maintained at 37°C, 5% CO2 for 24 hours, at which time the cells 
were approximately 60% confluent. Stimulation with platelet-derived growth 
factor (PDGF; 20 ng/mL) or endothelin (ET-1; 100 nM), or pretreatment with 
FK506 and CsA (1 µM each) was performed as detailed in the Results section. 
Immunostaining and quantitation of NFAT nuclear localization was performed as 
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 detailed previously (Gonzalez Bosc et al., 2005). All NFAT antibodies were 
purchased from Santa Cruz Biotechnology (Santa Cruz, Ca, USA).  
 
 Semi-quantitative RT-PCR. Approximately 100 mg sections of mouse urinary 
bladder detrusor muscle, denuded of urothelium, were homogenized in TRIZOL 
reagent (Sigma) using motorized homogenizer and the RNA was isolated as per 
the manufacturer's protocol. The cDNA was generated using the Superscript 
First-Strand cDNA kit (Invitrogen) according to the manufacturer's protocol. 
Primers for KV2.1 (forward: 5'-TGGACAT CGTGGTGGAGAA-3', reverse: 5'-
CAGATACTCTGATCCCGAG-3') were described previously (Thorneloe and 
Nelson, 2003). Primers for the α- and β-subunits of the BK channel (GenBank 
accession numbers L16912 and AF020711, respectively) were as follows: α-BK 
forward: 5'-AGTCTGCATCTTTGGGGATG-3', reverse: 5'-
TGTCCATTCCAGGAGGTGT-3'; β-BK forward: 5'-
TTCTGCACCTCAAGTCAACG-3', reverse: 5'-GACAGCGTCATTGCAGG TAA-
3'. RT-PCR was performed using the Fail-Safe PCR kit (Epicenter) with Amplitaq 
Gold DNA polymerase. For semi-quantitative analysis of K+ channel expression, 
PCR reactions were terminated at a point empirically determined to lie within the 
logarithmic phase (33 cycles for KV2.1 and the α- and β-BK subunits) and 
expressed relative to the housekeeping gene, β-actin (23 cycles). Densitometry 
of bands in ethidium bromide-stained agarose gels was determined using the 
Quantity One imaging analysis software (Bio-Rad). 
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  Statistical analyses. The summary data are presented as means ± S.E.M. 
unless indicated otherwise. Statistical significance was determined using 
Student's t-test (unpaired or paired) with a P value less than 0.05 being 
considered statistically significant. 
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 RESULTS 
 
 Expression and stimulation of NFAT nuclear localization in urinary bladder 
smooth muscle. We have previously reported that NFATc3 and NFATc4 are 
expressed in cerebral vascular and ileal smooth muscle (Stevenson et al., 2001; 
Gomez et al., 2002). In primary cultured UBSM myocytes, immunohistochemistry 
reveals expression of NFATc1, NFATc3, and NFATc4 (Figure 1A). Similarly, RT-
PCR analysis of fresh UBSM detrusor tissue indicates that NFATc1, NFATc3, 
and NFATc4 are present (Figure 1B). There was no evidence for NFATc2 
expression by either method, a finding that is consistent with previously 
published reports on the absence of NFATc2 expression in native smooth muscle 
(Stevenson et al., 2001; Gomez et al., 2002). 
 The smooth muscle mitogens PDGF and ET-1 are able to stimulate NFATc3 
nuclear translocation in ileal and cerebral vascular smooth muscle tissues 
(Stevenson et al., 2001; Gomez et al., 2002) and have been suggested to play a 
role in the physiology and pathophysiology of the urinary bladder (Saenz de 
Tejada et al., 1992; Khan et al., 1999; Adam et al., 2003). To determine if these 
growth factors are able to activate NFATc3 in UBSM, we treated primary cultured 
UBSM myocytes with either ET-1 (100 nM) or PDGF (20 ng/mL) for 30 min and 
quantified NFATc3 nuclear accumulation using confocal microscopy. Exposure to 
either ET-1 or PDGF led to a significant increase in NFATc3 nuclear 
accumulation (p < 0.05; 3.3 ± 0.6 and 3.4 ± 0.5 fold increase over media alone 
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 for ET-1 and PDGF, respectively; Figure 1C). ET-1- and PDGF-dependent 
nuclear translocation was blocked by pre-incubation of the cells with the 
calcineurin inhibitors FK506 and CsA (1 μM each). Thus, NFAT is expressed in 
intact and cultured UBSM tissue and nuclear translocation of NFATc3 can be 
induced by physiologically relevant agents. 
 
 UBSM strips from NFATc3-null mice exhibit enhanced contractility. We have 
previously reported that the NFATc3 isoform is expressed in vascular and ileal 
smooth muscle (Stevenson et al., 2001; Gomez et al., 2002) and regulates the 
expression of the contractile protein smooth muscle α-actin (Gonzalez Bosc et 
al., 2005). NFATc3 has also been implicated in the regulation of both BK and KV 
channels in vascular smooth muscle (Amberg et al., 2004; Nieves-Cintron et al., 
2006), suggesting that the NFATc3 isoform may be an important factor in the 
regulation of smooth muscle function. To determine if NFATc3 modulates the 
contractility of UBSM, we compared the force generated by UBSM strips taken 
from NFATc3-null and wild-type mice in response to EFS.   
 Representative myograph recordings obtained from UBSM strips from wild-
type and NFATc3-null mice are presented in Figure 2A, and the averaged force-
frequency plot is presented in Figure 2B. UBSM strips from NFATc3-null mice 
generated more force than strips from wild-type mice at all stimulation 
frequencies greater than 5 Hz (n = 16 strips from 3 animals each; p < 0.05). At 20 
Hz, the mean force generated by NFATc3-null UBSM strips was approximately 
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 1.8-fold that of strips from wild-type animals. Direct membrane potential 
depolarization of UBSM strips with 60 mM K+ in the bath did not result in a 
statistically significant difference in the contractile response between wild-type 
and NFATc3-null animals (p > 0.05; 10.6 ± 2.9 mN for wild-type and 8.5 ± 1.5 mN 
for NFATc3-null mice; n = 13), suggesting that the contractile response to 
membrane potential depolarization and activation of L-type voltage dependent 
Ca2+ channels (L-VDCC) are unchanged in NFATc3-null mice. The enhanced 
contractile response to EFS of UBSM strips taken from NFATc3-null mice 
suggests that the NFATc3 isoform contributes to the regulation of detrusor 
smooth muscle contractility, but not directly through L-VDCCs. 
 
 UBSM strips from NFATc3-null mice exhibit reduced sensitivity to the BK 
channel blocker, IBTX. Muscle contractions are dependent upon the 
concentration of cytosolic Ca2+.The overall contractility of UBSM tissues will be 
determined by the net contribution of factors that tend to increase Ca2+ influx, 
which is mediated principally by L-VDCCs, and those factors that hyperpolarize 
the cell membrane. In UBSM, much of this hyperpolarizing current is due to K+ 
current through BK and KV channels (Heppner et al., 1997; Thorneloe & Nelson, 
2003). Therefore, we focused on identifying potential changes in the activity 
and/or expression of BK and KV channels as factors mediating the enhanced 
contractility of the NFATc3-null UBSM strips. 
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  BK channels play a central role in the repolarization of the UBSM action 
potential and have been shown to figure prominently in the contractility of the 
bladder detrusor (Heppner et al., 1997). Blocking BK channels with the scorpion 
venom iberiotoxin (IBTX) increases the contractility of UBSM strips by shifting the 
force-frequency relationship to the left and by increasing the maximum force 
generated in response to muscarinic or purinergic stimulation, or to EFS 
(Heppner et al., 1997; Herrera et al., 2001; Petkov et al., 2001; Thorneloe et al., 
2005; Werner et al., 2006). To determine whether a decrease in BK channel 
activity might account for the increased contractility of bladder strips from 
NFATc3-null mice, we evaluated the effects of IBTX on the EFS-induced 
contractions of UBSM strips from NFATc3-null and wild-type mice. 
Representative recordings obtained before and after the application of IBTX are 
presented in Figure 3A. IBTX increased the amplitude of EFS-induced 
contractions in UBSM strips from both wild-type and NFATc3-null mice. However, 
IBTX treatment has a greater effect on the contractile response of UBSM strips 
taken from wild-type mice than on strips from NFATc3-null mice. For example, at 
5 Hz the contraction amplitude in the wild-type UBSM strips was increased 2.2 ± 
0.07 fold by treatment with IBTX, but was increased only 1.5 ± 0.02 fold in the 
NFATc3-null mice (n = 6; p < 0.05). The decreased responsiveness of NFATc3-
null UBSM strips to IBTX treatment suggests that BK channel activity is 
downregulated in these animals, which may account for the increase contractility 
previously noted in UBSM strips from NFATc3-null mice. In support of this, the 
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 force-frequency relationships of the NFATc3-null and wild-type mice are not 
significantly different when BK channels are blocked with IBTX (Figure 3B; 
compare with Figure 2B). These results indicate that the enhanced contractile 
response of UBSM strips from NFATc3-null mice is due to a reduction in BK 
channel activity.   
 
 BK currents are reduced in UBSM myocytes from NFATc3-null mice. UBSM 
strips from NFATc3-null mice displayed a reduced sensitivity to IBTX, which we 
interpreted as reflecting a decrease in the activity or expression of BK channels. 
To explore this possibility, we compared whole cell currents elicited by 10 mV 
voltage steps from -70 to + 70 mV from myocytes obtained from NFATc3-null and 
wild-type mice. Currents were recorded before and after the application of IBTX 
to selectively block BK channels. An evaluation of the total K+ currents (IK) 
recorded before the application of IBTX revealed no significant difference in 
either end-pulse or tail currents between the myocytes isolated from wild-type or 
NFATc3-null mice. Representative recordings are presented in Figure 4A and 
averaged I-V plots for the end-pulse and tail currents are presented in Figure 4B.  
 Although there was no significant difference in the total K+ currents, the BK 
current, i.e. IBTX-sensitive current, was significantly reduced in UBSM cells from 
NFATc3-null mice (representative recordings in Figures 5A & B). As shown in 
Figure 5C, the IBK was significantly lower in UBSM myocytes from NFATc3-null 
animals at all membrane potentials more positive than -20 mV (p < 0.05). At +40 
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 mV, the IBK was 4.1 ± 0.8 pA/pF (n = 9) for wild-type myocytes, but was only 1.2 
± 0.6 pA/pF (n = 10) for NFATc3-null myocytes, a ~70% reduction in IBK. Thus, 
despite the similarity in total K+ currents (IK), BK currents are reduced in 
myocytes isolated from NFATc3-null mice. The downregulation of BK currents in 
UBSM myocytes from NFATc3-null mice is consistent with the contractility data 
and supports the hypothesis that the enhanced contractile response of UBSM 
strips taken from these mice is due to a reduction of BK channel activity. 
 
 BK channel expression is downregulated in NFATc3-null mice. The UBSM 
BK channel is composed of a pore-forming α-subunit and a smooth muscle-
specific regulatory β1-subunit, the presence of which increases the apparent 
sensitivity of the BK channel to internal Ca2+ levels and voltage (Brenner et al., 
2000; Cox & Aldrich, 2000; Petkov et al., 2001). It is possible that expression of 
both the pore-forming α-subunit and the modulatory β1-subunits are altered in 
the NFATc3-null mice. Therefore, we used semi-quantitative RT-PCR to quantify 
the expression levels of mRNA for both the BK α- and BK β1-subunits 
(representative agarose gel in Figure 6A). There was no significant difference in 
the expression of mRNA for the β1-subunit between wild-type and NFATc3-null 
mice (p>0.05; Figure 6B). However, the expression of mRNA for the pore-forming 
α-subunit was 26% lower in UBSM from NFATc3-null mice than in wild-type mice 
(α-subunit : β1-subunit ratio of 0.99 ± 0.04 in wild-type mice vs. 0.71 ± 0.02 in 
NFATc3-null mice p<0.05; n = 3; Figure 6C). Thus, the reduction in BK currents 
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 in UBSM myocytes from NFATc3-null mice is supported at the molecular level by 
a decrease in the expression of the pore-forming α-subunit of the BK channel. 
 A reduction in the expression of the pore-forming α-subunit of the BK 
channel should not affect the channel open probability (Po), but should lead to a 
reduction in the channel density, i.e. there should be fewer channels per patch. In 
contrast, a loss of β1-subunit expression should dramatically lower the single 
channel Po (Brenner et al., 2000). To examine this possibility, we evaluated 
single BK channel currents measured in excised inside-out patches to determine 
if there was any difference in the open probabilities of BK channels isolated from 
wild-type or NFATc3-null UBSM myocytes (Figure 7A). All recordings were made 
in symmetrical 140 mM K+ and with intracellular 10 µM Ca2+. There was no 
significant difference in the Po at negative (-40 mV) or positive (+ 40 mV) 
membrane potentials (Figure 7B; p>0.05; n = 9). However, the BK channel 
density was significantly lower (Figure 7C; p<0.05; n = 9) in the excised patches 
isolated from NFATc3-null myocytes (1.3 ± 0.7 channels per patch) than for the 
wild-type UBSM myocytes (2.6 ± 1.3 channels per patch). These data indicate 
that the reduction in the whole-cell IBK noted previously (Figure 5C) is due to a 
downregulation in BK channel density. 
 
  UBSM myocytes isolated from NFATc3-null mice have increased KV 
currents. Our observation that the total IK in wild-type and NFATc3-null mice was 
similar (Figure 4B), despite a significant decrease in IBK in the NFATc3-null mice 
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 (Figure 5C), was initially puzzling. However, the total outward K+ current (IK) in 
UBSM is comprised of currents through multiple families of K+ channels 
(Heppner et al., 1997; Imai et al., 2001; Buckner et al., 2002; Herrera & Nelson, 
2002), so it was conceivable that an upregulation in another class of K+ channels 
might compensate for the reduction in BK current in the NFATc3-null mice. While 
our findings thus far suggest that BK channels may be a target of NFATc3 
transcriptional regulation, there are reports that NFATc3 may be a transcriptional 
regulator of KV channel expression (Amberg et al., 2004; Rossow et al., 2004). 
Thus, we investigated the possibility that an upregulation of KV channel activity in 
UBSM myocytes from NFATc3-null mice might compensate for the decrease in 
IBK and account for the observed similarities in total IK.  
 The wild-type murine UBSM KV current is insensitive to block by 4-AP, but is 
subject to block by TEA with an IC50 of 5.2mM (Thorneloe & Nelson, 2003). Thus, 
to determine if the KV component (IKV) of IK was altered in UBSM myocytes from 
NFATc3-null mice, we evaluated whole-cell currents elicited by 10 mV membrane 
potential steps before and after the application of 5 mM TEA (representative 
voltage steps in Figures 8A and B for wild-type and NFATc3-null myocytes, 
respectively). All recordings were also made in the presence of IBTX to block BK 
channels. As shown in the Figure 8C, the TEA-sensitive current (IKV), defined as 
the current blocked by the addition of 5 mM TEA in the presence of IBTX, is 
significantly larger in the NFATc3-null UBSM myocytes at all membrane 
potentials more positive than -20 mV (p < 0.05; Fig. 4B). At +40 mV, the IKV was 
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 5.40 ± 1.31 pA/pF for the NFATc3-null mice and only 2.18 ± 0.32 pA/pF for the 
wild-type myocytes (n = 7). These results indicate that the similarity in total K+ 
currents (IK) between UBSM myocytes from NFATc3-null and wild-type mice, 
despite the significantly reduced BK current (IBK) in the NFATc3-null myocytes, is 
likely due to a compensatory upregulation in TEA-sensitive KV currents (IKV).  
 
 Biophysical and molecular evidence for increased KV2.1 expression in 
NFATc3-null mice. The wild-type mouse UBSM KV channel is most likely a 
heteromultimeric assemblage composed of pore-forming KV2.1 subunits 
combined with KV5.1 and/or KV6 subunits (Thorneloe & Nelson, 2003). The 
simplest explanation for the observed increase in KV current in the NFATc3-null 
mice would be an upregulation of the native KV channel complexes, without any 
change in subunit composition. However, it is also possible that the changes in 
KV activity may be due to alterations in the subunit composition of the channels. 
To distinguish between these two possibilities, we compared some of the 
biophysical and pharmacological properties of the KV currents of isolated 
myocytes of wild-type and NFATc3-null mice. There was no significant difference 
in the steady-state activation curves of currents from myocytes isolated from 
NFATc3-null or wild-type mice (Figure 9A). The slope factors (k) of the activation 
curves for the wild-type (n = 5) and NFATc3-null mice (n = 7) were 16.31 ± 3.3 
and 17.6 ± 4.1, respectively (p > 0.05). Similarly, comparison of the activation 
time constants (Figure 9B) also revealed no significant difference between UBSM 
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 myocytes from NFATc3-null and wild-type mice (p < 0.05). In addition, neither the 
wild-type nor the NFATc3-null UBSM tissues strips responded to treatment with 
4-aminopyridine (4-AP; data not shown), indicating that a change in the 
expression of 4-AP sensitive KV family members (KV1 and KV4), did not 
contribute to the difference between the wild-type and NFATc3-null responses. 
Thus, the biophysical similarities and the lack of responsiveness to 4-AP suggest 
that the upregulation in KV current in the NFATc3-null myocytes is likely due to 
increased expression of the native channel complex rather than the expression of 
an alternative channel assemblage. 
 To determine if the upregulation in KV current was supported at the molecular 
level, we performed semi-quantitative RT-PCR to compare the levels of mRNA 
for KV2.1, which has previously been reported to be regulated by NFATc3 
(Amberg et al., 2004; Rossow et al., 2004), in UBSM from wild-type and NFATc3-
null mice (representative ethidium bromide-stained agarose gel in Figure 9C). 
Consistent with the increase in KV current, UBSM from NFATc3-null mice 
exhibited a 40% increase in the expression of mRNA for KV2.1 relative to that 
from the wild-type mice (p < 0.05; n = 3 animals each; Figure 9D). Thus, these 
data suggest that the similarity in total IK between NFATc3-null and wild-type 
mice, despite a downregulated IBK in the NFATc3-null mice, is due to a 
compensatory upregulation in IKV, supported at the molecular level by an 
increase in the expression of mRNA for KV2.1 
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 DISCUSSION 
 
 In this study, we have found that NFATc3 plays a role in the regulation of 
UBSM contractility by regulating the expression of BK and KV channels. UBSM 
tissue strips from NFATc3-null mice generate more force in response to EFS 
compared to strips from wild-type mice. We attribute this enhanced contractility to 
a reduction in BK channel activity. This interpretation is supported at the 
molecular level by a reduction in BK α-subunit expression in the NFATc3-null 
UBSM myocytes, and at the electrophysiological level by a significant reduction 
in BK current (IBK) and in the BK channel density. However, the total K+ current 
(IK) is similar in both NFATc3-null and wild-type mice, an observation that can be 
explained by a compensatory upregulation in KV current (IKV) in the NFATc3-null 
mice that is supported at the molecular level by an increase in the expression of 
mRNA for the KV2.1 subunit, a major component of the mouse UBSM KV channel 
complex.  
 Our observation that the net contractility in the NFATc3-null mice is 
increased despite the presence of an enhanced KV current suggests that, at least 
in response to EFS, the downregulation of BK currents plays a more significant 
role than the upregulation of KV currents. Presumably, this is due to the 
prominent role of the BK channel in the repolarization phase of the action 
potential (Heppner et al., 1997; Herrera et al., 2000; Herrera & Nelson, 2002), 
where a small decrease in BK channel activity could lead to a relatively large 
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 increase in force. Furthermore, the observation that the force-frequency 
relationships in UBSM strips from NFATc3-null and WT mice were identical in the 
presence of the BK channel blocker IBTX suggests that modulations of other 
channel types (e.g. KV) do not impact EFS-induced contractions as significantly 
as do the change in BK channel activity. Although it is conceivable that changes 
in the activity or expression of voltage-dependent Ca2+ channels (L-VDCC) in the 
NFATc3-null mice could lead to an increase in Ca2+ influx and, hence, greater 
contractile response, we did not find a significant difference in the amplitude of 
the contractile response to K+ (60 mM)-mediated depolarization between UBSM 
muscle strips isolated from NFATc3-null and wild-type mice, suggesting that L-
VDCC expression was unchanged.  
 Several families of K+ channels are expressed in UBSM including 
voltage-dependent K+ channels (KV), large-conductance Ca2+-activated K+ 
channels (BK), small-conductance Ca2+-activated K+ channels (SK), and ATP-
dependent K+ channels (KATP). In the absence of a channel opener, KATP 
channels contribute little, if anything, to UBSM contractility and it has been shown 
that glibenclamide does not have a significant effect on UBSM contractile activity 
(Imai et al., 2001). Furthermore, KATP channel activity is independent of voltage, 
and therefore would not contribute to the voltage-dependent K+ current. In 
contrast, blocking BK, SK, or KV channels leads to significant changes in phasic 
contraction amplitude and/or frequency (Heppner et al., 1997; Herrera & Nelson, 
2002; Hashitani & Brading, 2003a, b). The absence of a significant difference in 
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 the total IK between the NFATc3-null and wild-type mice seems to be explained 
by the reciprocal changes in BK and KV channel expression and activity that we 
have described. Quantitatively, our data would support this hypothesis given that, 
at +40 mV, the BK current was reduced by ~3 pA/pF, while the KV current was 
elevated by approximately the same amount. However, we cannot rule out the 
possibility that alterations to SK channel expression or activity, which we did not 
examine, may have contributed as well, as these channels have been previously 
demonstrated to also play a role in the contractility of UBSM tissues (Creed et al., 
1983; Herrera & Nelson, 2002; Hashitani & Brading, 2003b; Herrera et al., 2005). 
 Our observation that KV currents and KV2.1 channel expression are 
upregulated in UBSM from NFATc3-null mice is consistent with previous reports. 
In rats, sustained administration of angiotensin II (ANG II) leads to a reduction in 
TEA-sensitive KV currents and in mRNA for KV2.1 in cerebral arteries (Amberg et 
al., 2004). This downregulation is blocked by the calcineurin/NFAT inhibitor 
cyclosporine A (CsA), and is also abrogated in NFATc3-null mice. Similarly, 
Santana and colleagues (Rossow et al., 2004) found that after surgically-induced 
myocardial infarction (MI), TEA-sensitive KV currents and KV2.1 mRNA levels are 
reduced in cardiac tissue from mice. Administration of CsA prevented the 
reduction in KV currents post-MI, NFATc3-null mice did not exhibit the decrease 
in KV currents post-MI, and the expression of a constitutively active form of 
NFATc3 recapitulated these changes in KV current in the absence of MI. Thus, 
these previous reports strongly suggest that NFATc3 mediates the 
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 downregulation of KV2.1 channel expression and activity, similar to what we have 
reported in this current study.  
 We have found evidence for the downregulation of basal BK channel 
expression and activity in UBSM from NFATc3-null mice at multiple levels, 
including a reduction in BK α-subunit expression and channel density, a 
reduction in IBTX-sensitive BK current, and a reduced responsiveness of UBSM 
muscle strips to IBTX treatment. Recently, Santana and colleagues (Nieves-
Cintron et al., 2006) have reported that NFATc3 downregulates the expression of 
the β1-subunit of the BK channel in the arterial smooth muscle. In our current 
work, we found no evidence at the molecular level for a downregulation of β1-
subunit expression in the NFATc3-null urinary bladders. This may reflect tissue-
specific differences in NFATc3 regulatory patterns. 
Sequence analysis of putative 5' upstream regulatory regions of the KV2.1 
gene from mouse, human, and rat genomes reveals 15 potential NFAT 
consensus binding sites (-GGAAA-) within 3600 base pairs of the transcriptional 
initiation site. Analysis of the promoter regions for the human and mouse BK 
channel α-subunit reveals eight potential NFAT binding sites within 2600 base 
pairs of the initiation site, two of which are conserved in both the human and 
mouse genome. Thus, both the KV2.1 and the BK α-subunit genes could 
potentially be targets of NFAT regulation. In theory, NFATc3 might directly 
regulate the expression of both genes. However, this possibility seems unlikely 
since the opposing influences of these two transcriptional events create an 
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 outcome that is physiologically contradictory. More likely, NFATc3 is directly 
involved in regulating either KV2.1 or the BK α-subunit, but not both. In this 
scenario, the complimentary change in the non-NFATc3 regulated gene might 
constitute an example of developmental compensation that would serve to 
maintain membrane potential within a normal physiological range. Although it has 
been previously proposed that NFATc3 may directly downregulate KV2.1 
(Amberg et al., 2004; Rossow et al., 2004), neither our data nor the results of 
these previous studies definitively rule out the possibility that the changes in 
KV2.1 expression are an indirect consequence of NFATc3 action on an 
alternative target. Additional experimental approaches - including the use of 
promoter-reporter constructs or chromatin binding assays to establish functional 
significance of putative NFAT binding sites, or temporally controlled disruptions 
of NFATc3 using siRNA/antisense or dominant negative approaches to 
determine immediate and secondary consequences of NFAT inhibition - will be 
required to deconvolute the underlying molecular events. 
 In conclusion, our data indicates that that the transcription factor NFATc3 
plays a role in regulating the contractility of UBSM tissues through the regulation 
of the expression of BK and KV channels. We have found that the NFATc1, c3, 
and c4 isoforms are expressed in UBSM tissues and nuclear translocation of 
NFATc3 is stimulated by physiologically relevant mitogens (PDGF and ET-1). 
UBSM tissue strips from NFATc3-null mice are more contractile than strips from 
wild-type mice, and this enhanced contractility is attributable to a decrease in the 
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 expression and activity of BK channels. The total K+ currents in NFATc3-null and 
wild-type mice are statistically similar, an observation due, at least in part, to a 
concomitant upregulation in KV current and KV2.1 channel expression. It is 
unclear presently if the BK channel or/and the KV2.1 channel are both direct 
targets of NFATc3 regulation, or if the expression of one is directly regulated by 
NFATc3 activity and the reciprocal change in the other channel is a 
compensatory event. 
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Figure 1. NFAT expression in murine UBSM cultured cells and tissue. A. 
Immunostaining of primary cultures of UBSM myocytes indicates that murine 
UBSM expresses the NFATc1, NFATc3, and NFATc4 isoforms. NFAT 
expression is shown in red, nuclear staining in green, and regions of NFAT 
nuclear localization in white. Some nuclei exhibit NFATc3 nuclear localization 
under these basal conditions. B. RNA extracted from UBSM tissues was probed 
for presence of mRNA for NFATc1-c4 using RT-PCR. RNA isolated from thymus 
and heart tissue was used as a positive control. NFATc2 was not detected by 
either method. C. The extent of NFAT nuclear localization in response to 
stimulation with ET-1 or PDGF was determined using confocal microscopy. 
Treatment with either mitogen lead to a significant increase in NFATc3 nuclear 
translocation as compared to controls (*p < 0.05; c = number of cells analyzed). 
Treatment with FK506 and CsA (1 µM each) prior to the addition of the PDGF or 
ET-1 blocked NFATc3 nuclear translocation.  
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 Figure 2. UBSM strips from NFATc3-null mice are more contractile than 
strips from wild-type mice. A. Representative myograph recordings obtained 
from UBSM tissue strips from wild-type and NFATc3-null mice subject to 
electrical field stimulation from 1- 50 Hz. B. UBSM tissues strips from NFATc3-
null mice exhibited a greater contractile response than UBSM strips from wild-
type mice at all frequencies of stimulation greater than 5 Hz (*p < 0.05; n = 3 
animals and 16 strips each).  
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Figure 3. UBSM strips from NFATc3-null mice display a reduced 
responsiveness to IBTX. A. UBSM strips from wild-type and NFATc3-null mice 
were stimulated with EFS (1 - 50 Hz), exposed to IBTX (100 nM), and then re-
stimulated with EFS. B. In the presence of IBTX, there is no significant difference 
(p>0.05) in the amplitude of EFS-induced contractions of UBSM strips from wild-
type and NFATc3-null mice (compare with Figure 2B). 
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 Figure 4. UBSM myocytes from wild-type and NFATc3-null mice have 
similar total K+ currents (IK). A. Representative whole-cell current recordings 
elicited by 10 mV membrane potential steps from freshly isolated UBSM 
myocytes from wild-type and NFATc3-null mice. B. Analyses of the resulting end-
pulse and tail currents reveals no significant difference between the myocytes 
isolated from wild-type () and NFATc3-null mice ({) (p > 0.05).  
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 Figure 5. UBSM myocytes from NFATc3-null mice have reduced BK 
currents (IBK). A and B. Representative whole-cell current recordings elicited by 
10 mV membrane potential steps from freshly isolated UBSM myocytes from 
wild-type (A) and NFATc3-null mice (B) before and after the addition of IBTX to 
block BK channels. C. UBSM myocytes obtained from NFATc3-null mice ({) 
display reduced IBTX-sensitive BK currents (IBK) as compared to myocytes 
obtained from control mice () (*p < 0.05). 
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Figure 6. Reduced expression of the BK α-subunit in UBSM from NFATc3-
null mice. A. Representative electrophoresis gel of semi-quantitative RT-PCR 
analysis of RNA isolated from wild-type and NFATc3-null mice probed for β-actin, 
BK α-subunit, and BK β-subunits. B. There was no difference in the expression 
of mRNA for the β1-subunit (relative to β-actin) in UBSM from wild-type and 
NFATc3-null mice. C. UBSM myocytes isolated from NFATc3-null mice express 
significantly lower levels of the pore-forming BK α-subunit (relative to β1-subunit 
levels) (*p < 0.05; n = 3 animals each).  
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 Figure 7. Single channel recordings and BK channel density from wild-type 
and NFATc3-null myocytes. A. Representative single channel recordings from 
excised patches held at -40 and +40 mV. Arrows indicate closed state. B. There 
was no significant difference in open probabilities (Po) of excised BK channels 
isolated from wild-type or NFATc3-null UBSM myocytes. C. Current density is 
significantly reduced in UBSM myocytes from NFATc3-null mice (p<0.05; n = 9; 
error bars represent means ± S.D.). 
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 Figure 8. UBSM myocytes from NFATc3-null mice have elevated KV 
currents (IKV). A and B. Representative whole-cell current recordings elicited by 
10 mV membrane potential steps from freshly isolated UBSM myocytes from 
wild-type (A) and NFATc3-null mice (B) before and after the addition of TEA to 
block KV channels. All cells were also pretreated with IBTX to block BK channels. 
C. Analysis of the averaged difference currents from wild-type () and NFATc3-
null mice ({) after treatment with 5 mM TEA indicates that UBSM myocytes from 
NFATc3-null mice display significantly elevated TEA-sensitive KV currents (IKV) 
(*p < 0.05).       
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 Figure 9. Molecular and electrophysiological evidence for elevated KV2.1 
expression in NFATc3-null mice. A. There was no significant difference in the 
steady-state activation curves between UBSM myocytes obtained from wild-type 
and NFATc3-null mice (p > 0.05), or in the activation time constants (p < 0.05; 
mean ± S.E.M.) (B). C. UBSM tissue from wild-type type and NFATc3-null mice 
was probed for expression of mRNA for KV2.1 and β-actin. D. Comparison of the 
averaged ratios of KV2.1:β-actin in UBSM tissues indicates that the UBSM from 
NFATc3-null mice exhibit significantly more mRNA for KV2.1 than do UBSM 
tissues from wild-type mice (D) (*p < 0.05; n = 3 animals each). 
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CHAPTER 4: SYNOPSIS AND FUTURE DIRECTIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SYNOPSIS 
 
 Urinary bladder function can be compromised by any of a number of 
complications, but is most typically associated with bladder outlet obstruction due 
to enlargement of the prostate (cite). Despite the extensive research that has 
been performed on the functional and morphological changes that occur in the 
urinary bladder smooth muscle wall subsequent to outlet obstruction, very little is 
known regarding the molecular mechanisms that underlie these physiological 
changes. However, it is currently believed that many of the symptoms that are 
associated with bladder outlet obstruction, i.e. urinary incontinence and 
overactive bladder, may be due to changes in the contractile and electrical 
properties of the urinary bladder smooth muscle wall (cite). Changes in the 
contractile protein expression (cite), ion channel activity (cite), and Ca2+-handling 
(cite) have been reported to be downstream effects of outlet obstruction. Given 
the fact that its activity is controlled by intracellular Ca2+ levels and that it has 
previously been associated with alterations in the expression of contractile 
proteins (cite) and ion channels (cite), NFAT is a potential mediator of some of 
the physiological changes which occur in the bladder subsequent to outlet 
obstruction. In addition, the established role of NFAT as a mediator of cardiac 
hypertrophy (cite), a physiological response that may be considered analogous to 
bladder hypertrophy, lends additional support for NFAT in the bladder 
hypertrophic response. However, there is currently a dearth of information  
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regarding the expression and functional role of NFAT in the urinary bladder. 
Thus, the focus of this dissertation was to explore the role of NFAT in mediating 
the contractility of the urinary bladder. 
 
 In Chapter 1, we explored the role of NFAT as a mediator of contractile 
protein expression in smooth muscle tissues. Using a reporter construct 
containing a overlapping CArG/NFAT binding element, we determined that NFAT 
and SRF, another prominent transcription factor that has been implicated in the 
regulation of many smooth muscle-specific proteins (cite), cooperatively regulate 
the expression of smooth muscle α-actin. The fact that mutations to either the 
SRF- or NFAT-binding sites abolished reporter activity indicated that both 
transcription factors are required for SM α-actin expression. This is the first report 
of SRF and NFAT cooperatively regulating expression of a S-specific gene.  
In addition, our observation that blocking the calcineurin/NFAT pathways using 
FK506/CsA led to a reduction α-actin expression in smooth muscle cells 
indicates that NFAT activity may be physiologically relevant to normal SM 
contractile protein expression. 
 
 The focus of our experiments which we present in Chapter 2 of this 
dissertation focus on the functional role(s) of NFAT in urinary bladder smooth 
muscle. There are currently no published reports on the activity or expression of 
NFAT in UBSM tissues. Thus, our findings, which we have submitted for  
 174
 
publications, are novel observation in this field. Using a combination of RT-PCR 
and immunohistochemistry, we have identified 3 NFAT isoforms (NFATc1, c3, 
c4) in native and cultured UBSM. We were able to stimulate nuclear translocation 
of NFATc3 using PDGF and ET-1, two smooth muscle mitogens that have 
previously been shown to activate NFAT in smooth muscle (cite) and, in addition, 
may play a role in the bladder hypertrophic response (cite). Smooth muscle strips 
from NFATc3-null mice displayed an enhanced contractile response to electrical 
field stimulation as compared to strips from wild-type mice.  
 
 Electrophysiological analyses revealed that IBTX-sensitive BK currents 
were downregulated in the UBSM myocytes from NFATc3-null mice, and this 
downregulation of BK current was supported at the molecular level by a reduction 
in the expression of mRNA for the pore-forming α-subunit, although levels of the 
β-subunit, which increase the sensitivity of the channels to voltage and Ca2+, 
were not altered. Furthermore, we used excise inside-out patches to obtain 
single-channel recording that showed that there was no change in the voltage-
dependent activity of the NFATc3-null myocyte BK channels, also indicating that 
β-subunit expression was not altered. However, we did find a decrease in BK 
channel density in myocytes from the NFATc3-null mice; which is consistent with 
a downregulation of the pore-forming α-subunit. A recent publication (cite) has 
indicated that NFAT may also play a role in the regulation of the BK β-subunit in 
vascular smooth muscle tissue. However, our data did not find any change in β- 
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subunit expression in the UBSM of NFATc3-null mice. 
  
 Interestingly, the TEA-sensitive KV currents were upregulated in the 
NFATc3-null mice by approximately the same amount (~3pa/pf) as the BK 
currents were downregulated. This appears to be an adaptive response of the 
mice, although it is unclear which was done in response to which, i.e. did the 
changes in changes in BK channel activity occur in response to changes in KV 
activity, or vice-versa? Indeed, at this point it is unclear if either ion channel is 
even a direct genetic target of NFATc3. It is quite possible that the changes in BK 
and KV channel expression were both responses to a third, unidentified target of 
NFAT activity. However, we did identify potential NFAT binding sites in both 
promoters, but we have not performed reporter assays using constructs derived 
from the respective promoter regions to determine whether or not they are NFAT-
responsive.  
 
 In conclusion, in this dissertation we have shown that NFAT does play a 
role in the regulation of smooth muscle contractility via its role in modulating the 
expression of smooth muscle contractile proteins (α-actin) and ion channels (BK 
and KV). This lays the foundation for future experiments to determine the role of 
NFAT in the bladder hypertrophic response to outlet obstruction, which will be 
discussed in the next section. 
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FUTURE DIRECTIONS 
 
The role of NFAT in BK and KV channel expression 
Are the BK α-subunit and KV2.1 targets of NFAT transcriptional activity?  
 Although the data presented in Chapter 2 indicate that there are significant 
alterations in BK and KV channel expression in UBSM from NFATc3-null mice, 
we have yet to determine if these changes are directly mediated by NFATc3. To 
determine whether the BK α- and KV2.1-subunits are regulatory targets of 
NFATc3, we will construct reporters using the regions of the respective 
promoters that contain conserved NFAT recognition sites. The responsiveness to 
these reporters will be tested using classical Ca2+-elevating stimuli (ET-1, PDGF) 
that have previously been shown to activate NFAT nuclear translocation in 
smooth muscle (cite). Blockade of reporter activity using FK506 and CsA will lend 
further evidence in support, or rejection, of a role for NFAT in the expression of 
these two ion channel proteins. 
 Considering the fact that BK channel expression was downregulated in the 
NFATc3-cull mice while KV2.1 channel expression was upregulated, our findings 
suggest that NFATc3 normally upregulates BK channel expression and 
downregulates KV2.1 channel expression. Although NFAT transcriptional activity 
is most often associated with an increase in the expression of the target gene 
(cite), there is precedence for NFAT also acting to downregulate expression 
(cite). Since our findings suggest that NFATc3 downregulates KV2.1 expression,  
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one might conjecture that transfection of the KV2.1 reporter plasmid into the SMC  
line would lead to a basal level of expression that would, in the presence of 
NFAT-activating stimuli, then be decreased. 
 
In vivo analysis of the role of NFAT in the expression of KV2.1 and the BK α-
subunit 
 While the previous set of experiments will determine if KV2.1 and the α-
subunit are transcriptional targets of NFAT activity in cultured SMC, it would also 
be insightful to determine if the findings were also applicable in vivo. We will use 
a transgenic dominant-negative NFAT mouse (NFATdn) to determine the time-
course of the changes in BK and KV2.1 channel expression in live animals. NFAT 
activity in these mice can be "turned off" by feeding the mice dietary doxycycline. 
IBTX-sensitive BK and TEA-sensitive KV currents will be recorded from isolated 
UBSM myocytes derived from NFATdn mice before (time 0) and at various time 
points (24 hour intervals) after doxycycline treatment to determine the onset and 
progression of the changes in ion channel expression and activity. In addition to 
determining the in vivo functional relevance of NFAT in BK and KV channel 
expression, these data should also help to clarify whether the changes in BK and 
KV channel expression occur simultaneously, or if changes to one ion channel 
(e.g. BK) trigger a compensatory up- or downregulation in the activity of the other 
(i.e. KV) ion channel. 
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Are specific NFAT isoforms responsible for BK/KV channel transcriptional 
activity?  
 Lastly, we will use antisense RNA or siRNA to selectively determine 
exactly which NFAT isoforms are transcriptionally active in regards to BK and 
KV2.1 channel expression. Since we have shown that only NFATc1, c3, and c4 
are present in UBSM tissues, we will design siRNA probes that we will use to 
selectively inhibit expression of each of these isoforms (individually). After 
blocking the NFAT isoform, we will monitor the changes (if any) if the IBTX-
sensitive BK current and TEA-sensitive KV currents using patch-clamp analysis. It 
is quite possible that there is some redundancy in the ability of the NFAT 
isoforms to affect BK or KV channel expression, so we will also perform 
experiments in which multiple subsets of NFAT (e.g. NFATc1 and NFATc3) will 
be blocked at the same time. 
 
The role of NFAT in the bladder hypertrophic response to outlet obstruction 
 
Does NFAT activity play a role in the bladder response to partial bladder outlet 
obstruction? 
 In the first set of experiments, we will attempt to determine if NFAT activity 
plays a role in the bladder hypertrophic response that is initiated by partial 
bladder outlet obstruction. Wild-type mice will be subject to surgically-induced 
obstruction of the urethra. A subset of animals will be maintained on a diet  
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including the calcineurin/NFAT pathways inhibitor cyclosporine A (CsA). At daily 
time intervals, mice will be sacrificed and their bladders analyzed for various 
changes induced by the outlet obstruction. We will then compare the changes 
induced by the outlet obstruction between the normal diet animals and those 
maintained on dietary CsA to determine if blocking NFAT activation affected the 
outcome of the obstruction. Some of the parameters to be analyzed include: 
 1. Bladder : body mass ratio (wet weight) 
 2. Contractile response to electrical field stimulation (myograph) 
 3. Nuclear localization of NFAT isoforms (immmunostaining) 
 4. BK and KV currents (electrophysiology) 
 5. BK channel density (excised patch recordings) 
 6. Expression of smooth muscle proteins by Western Blot (e.g. α-actin, SM 
 myosin heavy chain, caldesmon) 
 
 These experiments can then be repeated using the NFATc3 mice which 
we have used in the experiments presented in this dissertation to determine the 
functional contribution of that specific isoform.      
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